<PAGE>
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
------------------
Date of Report (Date of earliest event reported): July 31, 1998
-------------------
BIO-VASCULAR, INC.
(Exact name of registrant as specified in its charter)
Minnesota 0-13907 41-1526554
(State of or other juris- (Commission (I.R.S. Employer
diction of incorporation) File Number) Identification No.)
2575 University Avenue, St. Paul, Minnesota 55114-1024
(Address of principal executive offices) (zip code)
Registrant's telephone number, including area code: (651) 603-3700
================================================================================
<PAGE>
ITEM 2. ACQUISITION OR DISPOSITION OF ASSETS.
On July 31, 1998 Bio-Vascular, Inc., a Minnesota corporation
("Bio-Vascular") acquired Jer-Neen Manufacturing Co., Inc., a Minnesota
corporation ("Jer-Neen"). The acquisition was completed pursuant to an
Acquisition Agreement and Plan of Reorganization dated as of such date (the
"Acquisition Agreement") by and among Bio-Vascular, Jer-Neen and Jer-Neen
Acquisition, Inc., a Minnesota corporation and a wholly-owned subsidiary of
Bio-Vascular (the "Acquisition Subsidiary"), and George Nelson, Jr., Ronald
Breckner, James Pfau, Willard Sykes and Catherine Sykes as the shareholders of
Jer-Neen (the "Shareholders"). Under the terms of the Acquisition Agreement,
Jer-Neen merged with and into the Acquisition Subsidiary, with the separate
existence of Jer-Neen ceasing and the Acquisition Subsidiary surviving (the
"Merger").
Pursuant to the terms of the Acquisition Agreement, all of the issued and
outstanding shares of common stock of Jer-Neen were converted into the right to
receive an aggregate of $1,750,000 in cash and an aggregate of 585,872 shares of
common stock, $.01 par value per share, of Bio-Vascular ("Bio-Vascular Common
Stock"), with all of such cash paid and shares issued at the closing of the
Merger. The total consideration paid by Bio-Vascular was determined pursuant to
arms' length negotiations and took into account various factors concerning the
business and prospects of Jer-Neen.
The number of shares of Bio-Vascular Common Stock issued in connection with
the Merger was determined pursuant to a letter of intent among Bio-Vascular and
each of the Shareholders, dated May 28, 1998. The letter of intent provided for
the stock portion of the consideration to consist of a number of shares of
Bio-Vascular Common Stock having an aggregate value of $2,750,000, based on the
average closing price of a share of Bio-Vascular Common Stock reported by the
Nasdaq National Market for (i) the ten consecutive trading days prior to public
announcement of execution of the letter of intent and (ii) the ten consecutive
trading days ending July 27, 1998. The 585,872 shares of Bio-Vascular Common
Stock issued to the Shareholders represented approximately 6.5% of the issued
and outstanding shares of Bio-Vascular Common Stock immediately prior to
issuance and approximately 6.1% of the issued and outstanding shares of
Bio-Vascular Common Stock immediately following issuance. All of the shares of
Bio-Vascular Common Stock issued to the Shareholders in connection with the
Merger are "restricted stock," as defined in the rules promulgated under the
Securities Act of 1933, as amended (the "Securities Act"), but the Acquisition
Agreement provides that Bio-Vascular will use reasonable best efforts to
register the resale of such shares under the Securities Act. Under the
Acquisition Agreement, Bio-Vascular will bear all registration, filing and
listing fees, printing expenses, fees and disbursements of counsel and
accountants for Bio-Vascular and all blue sky fees incurred in connection with
registration of such shares of Bio-Vascular Common Stock.
At the closing of the Merger Bio-Vascular also paid an additional $950,000
in cash allocated among the Shareholders in consideration of each Shareholder's
covenant under the Acquisition Agreement, for a period of ten years following
closing of the Merger, not to engage, directly or indirectly, in certain
activities competitive with the business conducted by Jer-Neen prior to the
Merger.
2
<PAGE>
The total cash portion of the consideration paid to the Shareholders for
their Jer-Neen stock and with respect to the non-competition covenants was paid
out of Bio-Vascular's existing cash at the time of the closing of the Merger.
Jer-Neen is a value-added manufacturer of precision components such as
micro coils, wire forms and spring components used in implantable
defibrillation, interventional medicine and other surgical applications within
the medical device industry. Following the Merger, Bio-Vascular will continue
Jer-Neen's business through the Acquisition Subsidiary, which has been re-named
Jer-Neen Manufacturing Co., Inc.
James F. Pfau will continue to manage Jer-Neen's business as the president
of the Acquisition Subsidiary pursuant to an Employment Agreement among Mr.
Pfau, Bio-Vascular and the Acquisition Subsidiary, dated July 31, 1998. The
Employment Agreement provides for an initial term of three (3) years. Under the
Employment Agreement Bio-Vascular will grant Mr. Pfau restricted shares of
Bio-Vascular Common Stock vesting over a period of four (4) years and options to
purchase Bio-Vascular Common Stock becoming exerciseable over a period of four
(4) years. Bio-Vascular and Mr. Pfau have also entered into a Change in Control
Agreement providing Mr. Pfau with certain benefits in the event of a change in
control of Bio-Vascular. Mr. Pfau's Employment Agreement and Change in Control
Agreement are filed as exhibits to this report and are incorporated herein by
reference. Following the Merger Mr. Pfau will also be appointed as a vice
president of Bio-Vascular.
For accounting purposes, it is intended that the Merger will be treated as
a purchase.
Additional information regarding the Merger is contained in the Acquisition
Agreement, which is an exhibit to this report and is incorporated herein by
reference.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
A. FINANCIAL STATEMENTS OF BUSINESS ACQUIRED.
Not applicable.
B. PRO FORMA FINANCIAL INFORMATION.
Not applicable.
C. EXHIBITS.
2.1 Acquisition Agreement and Plan of Reorganization by and among
Bio-Vascular, Inc., Jer-Neen Acquisition, Inc., Jer-Neen
Manufacturing Co., Inc., George Nelson, Jr., Ronald Breckner,
James Pfau, Willard Sykes and Catherine Sykes dated July 31,
1998.
3
<PAGE>
10.1 Employment Agreement dated July 31, 1998 among Bio-Vascular,
Inc., Jer-Neen Manufacturing Co., Inc. and James F. Pfau.
10.2 Change in Control Agreement dated July 31, 1998 between
Bio-Vascular, Inc. and James F. Pfau.
99.1 Press Release, dated June 2, 1998.
99.2 Press Release, dated August 3, 1998.
4
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
BIO-VASCULAR, INC.
Dated: August 14, 1998 By: /s/ Connie L. Magnuson
----------------------
Connie L. Magnuson
Vice President and Chief Financial Officer
5
<PAGE>
INDEX TO EXHIBITS
<TABLE>
<CAPTION>
Item Method of Filing
- ---- ----------------
<S> <C> <C>
2.1 Acquisition Agreement and Plan of Reorganization by and among Filed electronically
Bio-Vascular, Inc., Jer-Neen Acquisition, Inc., Jer-Neen herewith.
Manufacturing Co., Inc., George Nelson, Jr., Ronald Breckner, James
Pfau, Willard Sykes and Catherine Sykes dated July 31, 1998.
10.1 Employment Agreement dated July 31, 1998 among Bio-Vascular, Inc., Filed electronically
Jer-Neen Manufacturing Co., Inc. and James F. Pfau. herewith.
10.2 Change in Control Agreement dated July 31, 1998 between Filed electronically
Bio-Vascular, Inc. and James F. Pfau. herewith.
99.1 Press Release, dated June 2, 1998. Filed electronically
herewith.
99.2 Press Release, dated August 3, 1998. Filed electronically
herewith.
</TABLE>
<PAGE>
EXHIBIT 2.1
ACQUISITION AGREEMENT AND PLAN OF REORGANIZATION
BY AND AMONG
BIO-VASCULAR, INC.,
JER-NEEN ACQUISITION, INC.,
JER-NEEN MANUFACTURING CO., INC.,
GEORGE NELSON, JR.,
RONALD BRECKNER,
JAMES PFAU,
WILLARD SYKES
AND
CATHERINE SYKES
DATED AS OF JULY 31, 1998
<PAGE>
TABLE OF CONTENTS
-----------------
<TABLE>
<CAPTION>
Page
----
<S> <C>
ARTICLE I - DEFINITIONS..........................................................1
1.1. DEFINITIONS............................................................1
1.2. INTERPRETATION.........................................................5
ARTICLE II - THE MERGER AND THE SURVIVING CORPORATION............................6
2.1. THE MERGER.............................................................6
2.2. EFFECTIVE TIME OF THE MERGER...........................................6
2.3. ARTICLES OF INCORPORATION, BY-LAWS AND BOARD OF DIRECTORS OF
SURVIVING CORPORATION..................................................6
ARTICLE III - CONVERSION OF SHARES...............................................7
3.1. CONVERSION OF SHARES...................................................7
3.2. NEWCO SHARES...........................................................7
3.3. DELIVERY OF MERGER CONSIDERATION.......................................7
ARTICLE IV - CLOSING.............................................................7
4.1. CLOSING................................................................7
ARTICLE V. - REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS..................8
5.1. DUE ORGANIZATION AND QUALIFICATION.....................................8
5.2. AUTHORIZATION; NON-CONTRAVENTION; APPROVALS............................8
5.3. CAPITALIZATION AND OWNERSHIP...........................................9
5.4. SUBSIDIARIES...........................................................9
5.5. FINANCIAL STATEMENTS..................................................10
5.6. LIABILITIES AND OBLIGATIONS...........................................10
5.7. ACCOUNTS AND NOTES RECEIVABLE.........................................11
5.8. ASSETS................................................................11
5.9. MATERIAL CUSTOMERS AND CONTRACTS......................................12
5.10. PERMITS...............................................................12
5.11. ENVIRONMENTAL MATTERS.................................................13
</TABLE>
i
<PAGE>
5.12. LABOR AND EMPLOYEE RELATIONS.......................................14
5.13. INSURANCE..........................................................14
5.14. COMPENSATION; EMPLOYMENT AGREEMENTS................................14
5.15. NONCOMPETITION, CONFIDENTIALITY AND NONSOLICITATION AGREEMENTS.....14
5.16 EMPLOYEE BENEFIT PLANS.............................................14
5.17. LITIGATION AND COMPLIANCE WITH LAW.................................16
5.18. TAXES..............................................................17
5.19. ABSENCE OF CHANGES.................................................17
5.20. ACCOUNTS WITH BANKS AND BROKERAGES; POWERS OF ATTORNEY.............19
5.21. ABSENCE OF CERTAIN BUSINESS PRACTICES..............................19
5.22. RESERVED...........................................................19
5.23. INTANGIBLE PROPERTY................................................19
5.24. TAX REORGANIZATION REPRESENTATION..................................19
5.25. RESERVED...........................................................19
5.26. INVENTORY..........................................................19
5.27. PRODUCT LIABILITY CLAIMS...........................................19
5.28. YEAR 2000 COMPLIANCE...............................................20
5.29. WARRANTY OF PRODUCTS...............................................20
5.30. ISO-9002...........................................................20
5.31. INDIVIDUAL REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS......20
5.32. INDIVIDUAL REPRESENTATIONS AND WARRANTIES OF JAMES PFAU............21
5.33. DISCLOSURE.........................................................22
ARTICLE VI - REPRESENTATIONS AND WARRANTIES OF BVI AND NEWCO..................22
6.1. ORGANIZATION.......................................................22
6.2. AUTHORIZATION; NON-CONTRAVENTION; APPROVALS........................22
6.3. BVI SECURITIES.....................................................23
6.4. TAX REORGANIZATION REPRESENTATIONS.................................23
ii
<PAGE>
6.5. SEC FILINGS.........................................................24
6.6. DISCLOSURE..........................................................25
6.7. NO MATERIAL ADVERSE CHANGE..........................................25
6.8. NO PROCEEDINGS......................................................25
6.9. OWNERSHIP OF NEWCO; NO PRIOR ACTIVITIES.............................25
ARTICLE VII - CERTAIN COVENANTS...............................................26
7.1. FUTURE COOPERATION; TAX MATTERS.....................................26
7.2. EXPENSES............................................................26
7.3. LEGAL OPINIONS......................................................26
7.4. EMPLOYMENT AGREEMENTS...............................................27
7.5. REPAYMENT OF RELATED PARTY INDEBTEDNESS AND REAFFIRMATION OF LEASES.27
7.6. REGISTRATION STATEMENT ON FORM S-3..................................27
7.7. RESIGNATIONS........................................................31
7.8. RELEASE OF GUARANTIES...............................................31
7.9. INSURANCE...........................................................31
7.10. LIFE INSURANCE POLICIES............................................31
ARTICLE VIII - INDEMNIFICATION................................................31
8.1. GENERAL INDEMNIFICATION BY THE STOCKHOLDERS.........................32
8.2. INDEMNIFICATION BY BVI..............................................32
8.3. THIRD PERSON CLAIMS.................................................32
8.4. INDEMNIFICATION DEDUCTIBLE..........................................34
8.5. SUBROGATION.........................................................35
8.6. SURVIVAL OF REPRESENTATIONS AND WARRANTIES..........................35
8.7. ADDITIONAL NOTICE; COOPERATION......................................35
8.8. EXCLUSIVE REMEDY....................................................35
ARTICLE IX - NONCOMPETITION COVENANTS.........................................36
9.1. PROHIBITED ACTIVITIES...............................................36
iii
<PAGE>
9.2. EQUITABLE RELIEF...................................................36
9.3. REASONABLE RESTRAINT...............................................36
9.4. SEVERABILITY; REFORMATION..........................................37
9.5. MATERIAL AND INDEPENDENT COVENANT..................................37
ARTICLE X - NONDISCLOSURE OF CONFIDENTIAL INFORMATION.........................37
10.1. GENERAL............................................................37
10.2. EQUITABLE RELIEF...................................................37
ARTICLE XI - INTENDED TAX TREATMENT...........................................38
11.1. TAX-FREE REORGANIZATION............................................38
ARTICLE XII - FEDERAL SECURITIES ACT OF 1933 AND CONTRACTUAL RESTRICTIONS
ON BVI COMMON STOCK.............................................38
12.1. COMPLIANCE WITH LAW................................................38
12.2. ECONOMIC RISK; SOPHISTICATION......................................39
12.3. RULE 144 REPORTING.................................................39
ARTICLE XIII - MISCELLANEOUS..................................................40
13.1. SUCCESSORS AND ASSIGNS.............................................40
13.2. ENTIRE AGREEMENT...................................................40
13.3. COUNTERPARTS.......................................................40
13.4. BROKERS AND AGENTS.................................................40
13.5. NOTICES............................................................40
13.6. EXERCISE OF RIGHTS AND REMEDIES....................................42
13.7. REFORMATION AND SEVERABILITY.......................................42
13.8. THIRD PARTY BENEFICIARIES..........................................42
13.9. GOVERNING LAW; JURISDICTION; SERVICE OF PROCESS....................42
iv
<PAGE>
ACQUISITION AGREEMENT AND PLAN OF REORGANIZATION
------------------------------------------------
THIS ACQUISITION AGREEMENT AND PLAN OF REORGANIZATION (this "Agreement") is made
as of the 31st day of July, 1998, by and among Bio-Vascular, Inc., a Minnesota
corporation ("BVI"), Jer-Neen Acquisition, Inc., a Minnesota corporation that is
a subsidiary of BVI ("Newco"), Jer-Neen Manufacturing Co., Inc., a Minnesota
corporation (the "Company"), George Nelson, Jr., Ronald Breckner, James Pfau,
Willard Sykes and Catherine Sykes (such individuals being collectively referred
to herein as the "Stockholders"), with the Stockholders being the Company's only
stockholders.
WHEREAS, the respective Boards of Directors of Newco and the Company
(collectively referred to as "Constituent Corporations") deem it advisable and
in the best interests of the Constituent Corporations and their respective
stockholders that the Company merge with and into Newco (the "Merger"); and
WHEREAS, the Boards of Directors of the Constituent Corporations have approved
and adopted this Agreement as a plan of reorganization within the provisions of
Section 368 of the Internal Revenue Code of 1986, as amended (the "Code"); and
WHEREAS, the stockholders of the Constituent Corporations have approved the
Merger in accordance with the MBC Act.
NOW, THEREFORE, in consideration of the premises and of the mutual agreements,
representations, warranties, provisions and covenants contained herein, the
parties hereto, intending to be legally bound, agree as follows:
ARTICLE I
DEFINITIONS
1.1 DEFINITIONS. Capitalized terms used in this Agreement shall have the
following meanings:
"Affiliate" of, or "Affiliated" with, a specified person or entity means a
person or entity that directly, or indirectly through one or more
intermediaries, controls, or is controlled by, or is under common control with,
the specified person or entity.
"Agreement" has the meaning set forth in the first paragraph of this Agreement.
"Balance Sheet Date" has the meaning set forth in Section 5.5.
"Broker" has the meaning set forth in Section 13.4.
<PAGE>
"Business" means the business of manufacturing, distributing or selling
cardiovascular, related vascular, surgical and other medical-intervention
applications of engineered and specialized springs and wire forms.
"BVI" has the meaning set forth in the first paragraph of this Agreement.
"BVI Common Stock" means BVI's common stock, par value $.01 per share.
"Closing" has the meaning set forth in Section 4.1.
"Closing Date" has the meaning set forth in Section 4.1.
"Code" has the meaning set forth in the third paragraph of this Agreement.
"Company" has the meaning set forth in the first paragraph of this Agreement.
"Company Common Stock" has the meaning set forth in Section 3.1.
"Constituent Corporations" has the meaning set forth in the second paragraph of
this Agreement.
"Effective Time" has the meaning set forth in Section 2.2.
"Encumbrances" means all liens, encumbrances, mortgages, pledges, security
interests, conditional sales agreements, charges, options, preemptive rights,
rights of first refusal, reservations, restrictions or other encumbrances or
defects in title.
"Employee benefit plan" has the meaning set forth in Section 5.16.
"Employee pension benefit plan" has the meaning set forth in Section 5.16.
"Employment Agreements" has the meaning set forth in Section 7.4.
"Environmental Laws" means any Law or agreement with any Governmental Authority
relating to (a) the protection, preservation or restoration of the environment
(including, without limitation, air, water vapor, surface water, groundwater,
drinking water supply, surface land, subsurface land, plant and animal life or
any other natural resource) or to human health or safety or (b) the exposure to,
or the use, storage, recycling, treatment, generation, transportation,
processing, handling, labeling, production, release or disposal of any
substance, in each case as amended and as in effect on the Closing Date. The
term "Environmental Law" includes, without limitation, (i) the Federal
Comprehensive Environmental Response Compensation and Liability Act of 1980, the
Superfund Amendments and Reauthorization Act, the Federal Water Pollution
Control Act of 1972, the Federal Clean Air Act, the Federal Clean Water Act, the
Federal Resource Conservation and Recovery Act of 1976 (including the Hazardous
and Solid Waste Amendments thereto), the Federal Solid Waste Disposal and the
Federal Toxic Substances Control Act, the Federal Insecticide Fungicide and
Rodenticide Act, the Federal Occupational
2
<PAGE>
Safety and Health Act of 1970, each as amended and as in effect on the Closing
Date, and (ii) any common law or equitable doctrine (including, without
limitation, injunctive relief and tort doctrines such as negligence, nuisance,
trespass and strict liability) that may impose liability or obligations for
injuries or damages due to, or threatened as a result of, the presence of,
effects of or exposure to any substance.
"ERISA" has the meaning set forth in Section 5.16.
"ERISA Affiliate" has the meaning set forth in Section 5.16.
"Expiration Date" has the meaning set forth in Section 8.6.
"Financial Statements" has the meaning set forth in Section 5.5.
"GAAP" means generally accepted accounting principles, consistently applied by
the respective party.
"Governmental Authority" means any federal, state, local or foreign government,
political subdivision or governmental or regulatory authority, agency, board,
bureau, commission, instrumentality or court or quasi-governmental authority.
"Hazardous Substances" means any substance presently listed, defined, designated
or classified as hazardous, toxic, radioactive or dangerous, or otherwise
regulated, under any Environmental Law. The term "Hazardous Substances"
includes, without limitation, any substance to which exposure is regulated by
any Governmental Authority or any Environmental Law including, without
limitation, any toxic waste, pollutant, contaminant, hazardous substance, toxic
substance, hazardous waste, special waste, industrial substance or petroleum or
any derivative or by-product thereof, radon, radioactive material, asbestos or
asbestos containing material, urea formaldehyde foam insulation, lead or
polychlorinated biphenyls.
"Indemnified Party" has the meaning set forth in Section 8.3.
"Indemnifying Party" has the meaning set forth in Section 8.3.
"Interim Balance Sheet" has the meaning set forth in Section 5.5.
"Interim Financial Statements" has the meaning set forth in Section 5.5.
"Knowledge of the Stockholders" means the actual knowledge of any of the
Stockholders.
"Law" or "Laws" means any and all federal, state, local or foreign statutes,
laws, ordinances, code, regulations, published requirements, orders, decrees,
judgments, injunctions and rules of any Governmental Authority, including,
without limitation, those covering environmental, Tax, energy, safety, health,
transportation, bribery, recordkeeping, zoning, discrimination, antitrust and
wage and hour matters, in each case as amended and in effect from time to time.
3
<PAGE>
"Loss" or "Losses" means all liabilities, losses, damages, assessments,
adjustments, fees, costs and expenses (including specifically, but without
limitation, reasonable attorneys' fees and costs and expenses of investigation
and reasonable attorney's fees and costs and expenses relating to or arising
from any claim, action, suit, proceeding or demand), net of income tax effects
with respect thereto (including, without limitation, income tax benefits
recognized in connection therewith and income taxes upon any indemnification
recovery thereof) and net of any insurance proceeds, and any indemnity,
contribution or similar payment, collected by Newco, BVI or the Surviving
Corporation or any Affiliate thereof from any third party with respect thereto.
"Material Customers" has the meaning set forth in Section 5.9.
"Merger Consideration" has the meaning set forth in Section 3.1.
"Merger Filing" has the meaning set forth in Section 2.2.
"Merger" has the meaning set forth in the second paragraph of this Agreement.
"MBC Act" means the Minnesota Business Corporation Act, as amended.
"Newco" has the meaning set forth in the first paragraph of this Agreement.
"Noncompete Term" has the meaning set forth in Section 9.1(a).
"1933 Act" means the Securities Act of 1933, as amended.
"1934 Act" means the Securities Exchange Act of 1934, as amended.
"Permits" has the meaning set forth in Section 5.10.
"Permitted Encumbrances" means (a) liens for taxes, assessments and governmental
charges or levies (i) not yet due and payable or (ii) which are being contested
in good faith by appropriate proceedings and for which an appropriate reserve
has been established under GAAP; (b) Encumbrances imposed by Law, such as
materialmen's, mechanics', carriers', workmen's and repairmen's liens and other
similar liens arising in the ordinary course of business securing obligations
that are being contested in good faith by appropriate proceedings and for which
an appropriate reserve has been established under GAAP; (c) pledges or deposits
to secure obligations under workers' compensation laws or similar legislation or
to secure public or statutory obligations; (d) survey exceptions, reciprocal
easement agreements or other customary encumbrances on title to real property
that (i) were not incurred in connection with any indebtedness, (ii) do not
render title to the property encumbered thereby unmarketable or uninsurable, and
(iii) do not, individually or in the aggregate, adversely affect the value of or
the use of such property for its present purposes; and (e) Encumbrances
reflected in the Financial Statements.
4
<PAGE>
"Plan" has the meaning set forth in Section 5.16.
"Qualified Plans" has the meaning set forth in Section 5.16.
"Registrable Securities" has the meaning set forth in Section 7.6(f).
"Registration Statement" has the meaning set forth in Section 7.7(a)
"Restricted Shares" has the meaning set forth in Section 12.1.
"Rule 144" means Rule 144 as promulgated under the 1933 Act.
"SEC" means the Securities and Exchange Commission.
"Stockholders" has the meaning set forth in the first paragraph of this
Agreement.
"Surviving Corporation" has the meaning set forth in Section 2.1.
"Taxes" has the meaning set forth in Section 5.18.
"Territory" has the meaning set forth in Section 9.1.
"Third Person" has the meaning set forth in Section 8.3.
"Year-End Financial Statements has the meaning set forth in Section 5.5.
1.2. INTERPRETATION. For all purposes of this Agreement, except as otherwise
expressly provided or unless the context otherwise requires:
(a) the terms defined in Section 1.1 and elsewhere in this Agreement
include the plural as well as the singular;
(b) all accounting terms not otherwise defined herein have the meanings
ascribed to them in accordance with GAAP; and
(c) the words "herein," "hereof," and "hereunder" and other words of
similar import refer to this Agreement as a whole and not to any particular
Article, Section or other subdivision.
ARTICLE II
THE MERGER AND THE SURVIVING CORPORATION
2.1 THE MERGER. Upon the terms and subject to the conditions of this Agreement,
at the Effective Time in accordance with the MBC Act, the Company shall be
merged with and into Newco and the separate existence of the Company shall
thereupon cease. Newco shall be the
5
<PAGE>
surviving corporation in the Merger (hereinafter sometimes referred to as the
"Surviving Corporation").
2.2. EFFECTIVE TIME OF THE MERGER. The Merger shall become effective at such
time (the "Effective Time") as the articles of merger, in a form mutually
acceptable to BVI and the Company, are filed with the Secretary of State of the
State of Minnesota (the "Merger Filing"). The Merger Filing shall be made
simultaneously with or as soon as practicable after the execution of this
Agreement and the Closing.
2.3. ARTICLES OF INCORPORATION, BY-LAWS AND BOARD OF DIRECTORS OF SURVIVING
CORPORATION. As a result of the Merger and at the Effective Time, the following
shall occur:
(a) The Articles of Incorporation of Newco shall be amended as follows:
"FIRST. The name of the corporation is Jer-Neen Manufacturing Co.,
Inc."
(b) The Articles of Incorporation of Newco in effect immediately prior
to the Effective Time, as so amended hereby, shall become the Articles of
Incorporation of the Surviving Corporation. After the Effective Time, the
Articles of Incorporation of the Surviving Corporation may be amended in
accordance with their terms and as provided in the MBC Act.
(c) The Bylaws of Newco in effect immediately prior to the Effective
Time shall become the Bylaws of the Surviving Corporation, and thereafter may be
amended in accordance with their terms and as provided by the Articles of
Incorporation of the Surviving Corporation and MBC Act.
(d) The Board of Directors of Newco as constituted immediately prior to
the Effective Time shall be the Board of Directors of the Surviving Corporation.
ARTICLE III
CONVERSION OF SHARES
3.1 CONVERSION OF SHARES. At the Effective Time, by virtue of the Merger, and
without any action on the part of any holder of any capital stock of the
Company, the issued and outstanding shares of common stock, $10.00 par value per
share, of the Company as of the Effective Time (the "Company Common Stock")
shall be converted into the right to receive, and become exchangeable for,
$1,750,000 in cash and an aggregate of 585,872 shares of BVI Common Stock, which
cash and shares of BVI Common Stock shall be exchangeable for all the Company
Common Stock outstanding at the Effective Time and issued to or at the direction
of the Stockholders as set forth in Schedule 3.1 (the BVI Common Stock and cash
paid in exchange for the Company Common Stock being herein collectively referred
to as the "Merger Consideration").
6
<PAGE>
3.2. NEWCO SHARES. The outstanding shares of common stock, par value $.01 per
share, of Newco shall remain outstanding following the Merger.
3.3. DELIVERY OF MERGER CONSIDERATION. At the Closing, (a) each Stockholder
shall furnish to BVI the certificates representing its Company Common Stock,
duly endorsed in blank by such Stockholder or accompanied by duly executed blank
stock powers, and (b) BVI shall deliver to or at the direction of each
Stockholder cash (by wire transfer in accordance with the wiring instructions
for each Stockholder set forth on Schedule 3.1) and certificates representing
the shares of BVI Common Stock to be delivered to such Stockholder pursuant to
Section 3.1. Each Stockholder agrees promptly to cure any deficiencies with
respect to the endorsement of the certificates or other documents of conveyance
with respect to the Company Common Stock or with respect to the stock powers
accompanying such stock.
ARTICLE IV
CLOSING
4.1 CLOSING. The consummation of the Merger and delivery of the consideration
described in Section 3.3 hereof and the other transactions contemplated by this
Agreement (the "Closing") shall take place at the offices of Winthrop &
Weinstine, P.A. 3000 Dain Rauscher Plaza, 60 South Sixth Street, Minneapolis,
Minnesota, concurrently with the execution of this Agreement which date is
herein referred to as the "Closing Date."
ARTICLE V.
REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS
Each of the schedules referenced below shall be deemed to include the
information contained in all other schedules such that reference to a matter or
item contained in one schedule shall be deemed to constitute disclosure under
all other schedules. Without limiting the generality of the foregoing, the
listing of a document or item on the below-referenced schedules shall be deemed
to disclose an exception to a representation or warranty made in the Agreement
to the extent the representation or warranty addresses the existence of the
document or item or the existence of any liability arising out of the express
terms thereof.
In connection with and as an inducement to BVI to enter into and be bound by the
terms of this Agreement, the Stockholders in their individual capacities and,
with the exception of Section 5.31 and Section 5.32 of this Agreement, jointly
and severally represent and warrant to BVI as follows:
5.1. DUE ORGANIZATION AND QUALIFICATION. The Company is a corporation duly
organized, validly existing and in good standing under the Laws of the State of
Minnesota and is duly authorized and qualified to do business under all
applicable Laws and to carry on its business in the places and in the manner as
now conducted. The Company has the requisite power and authority to own, lease
and operate its assets and properties and to carry on its business as such
business is currently being conducted. Schedule 5.1 contains a list of all
jurisdictions in which the Company is authorized or qualified to do business.
True, complete and correct copies of the
7
<PAGE>
Articles of Incorporation and By-laws, each as amended, of the Company, are
attached hereto included as part of Schedule 5.1. Correct and complete copies of
all stock records and minute books of the Company have been provided to BVI.
5.2. AUTHORIZATION; NON-CONTRAVENTION; APPROVALS.
(a) The Company has the requisite power and authority to enter into
this Agreement and to effect the Merger. The execution, delivery and performance
of this Agreement have been approved by the board of directors of the Company
and by the Stockholders. No additional corporate proceedings on the part of the
Company are necessary to authorize the execution and delivery of this Agreement
and the consummation by the Company of the transactions contemplated hereby.
This Agreement has been duly and validly executed and delivered by the Company,
and, assuming the due authorization, execution and delivery hereof by BVI and
Newco, constitutes a valid and binding agreement of the Company, enforceable
against the Company in accordance with its terms, except as enforceability may
be limited by bankruptcy, insolvency, reorganization, moratorium or other
similar laws relating to or affecting creditors' rights or by general equitable
principles (regardless of whether such enforceability is considered in a
proceeding in equity or at law.)
(b) The execution and delivery of this Agreement by the Company does
not, and the consummation by the Company of the transactions contemplated hereby
will not, violate or result in a breach of any provision of, or constitute a
default (or an event which, with notice or lapse of time or both, would
constitute a default) under, or result in the termination of, or accelerate the
performance required by, or result in a right of termination or acceleration
under, or result in the creation of any Encumbrance upon any of the properties
or assets of the Company under any of the terms, conditions or provisions of,
(i) the Articles of Incorporation or Bylaws of the Company, (ii) any Laws
applicable to the Company or any of its properties or assets, or (iii) except as
set forth in Schedule 5.2, any note, bond, mortgage, indenture, deed of trust,
license, franchise, permit, concession, lease or other instrument, obligation or
agreement of any kind to which the Company is now a party or by which the
Company or any of its properties or assets may be bound or affected.
(c) Except for the Merger Filing and as set forth in Schedule 5.2, no
declaration, filing or registration with, or notice to, or authorization,
consent or approval of, any Governmental Authority or third party is necessary
for the execution and delivery of this Agreement by the Company or the
consummation by the Company of the transactions contemplated hereby. Except as
set forth in Schedule 5.2, none of the contracts or agreements with Material
Customers or contracts providing for purchases or services individually in
excess of $25,000, or other material agreements, licenses or permits, in each
case to which the Company is a party, requires notice to, or the consent or
approval of, any third party for the execution and delivery of this Agreement by
the Company and the Stockholders and the consummation of the transactions
contemplated hereby.
5.3. CAPITALIZATION AND OWNERSHIP. The authorized capital stock of the Company
consists solely of 2,500 shares of Company Common Stock, of which 200 shares are
issued and
8
<PAGE>
outstanding. All of the issued and outstanding shares of the Company Common
Stock have been duly authorized and validly issued, are fully paid and
nonassessable, and were offered, issued, sold and delivered by the Company in
compliance with all applicable Laws, including, without limitation, those Laws
concerning the issuance of securities. None of such shares were issued in
violation of the preemptive rights of any past or present stockholder. Except as
set forth in Schedule 5.3, no subscription, option, warrant, call, convertible
or exchangeable security, other conversion right or commitment of any kind
exists which obligates the Company to issue any of its capital stock.
5.4. SUBSIDIARIES. Except as set forth in Schedule 5.4, the Company owns, of
record or beneficially, or controls, directly or indirectly, no capital stock,
securities convertible into or exchangeable for capital stock or any other
equity interest in any corporation, association or other business entity. Except
as set forth in Schedule 5.4, the Company is not, directly or indirectly, a
participant in any joint venture, limited liability company, partnership or
other noncorporate entity.
5.5. FINANCIAL STATEMENTS.
(a) The Company has delivered to BVI complete and correct copies of the
following financial statements:
(i) the audited balance sheets of the Company as of October 31,
1997 and 1996 and the related audited statements of income,
retained earnings and cash flows for the years then ended,
together with the related notes, schedules and audit report of
the Company's independent accountants (such financial
statements and the related notes and schedules are referred to
herein as the "Year-End Financial Statements"); and
(ii) the unaudited balance sheet (the "Interim Balance Sheet") of
the Company as of May 31, 1998 (the "Balance Sheet Date") and
the related unaudited statements of income, retained earnings
and cash flows for the interim period ended on the Balance
Sheet Date (such financial statements referred to herein as
the "Interim Financial Statements"). The Year-End Financial
Statements and the Interim Financial Statements are
collectively referred to herein as the "Financial Statements"
and are attached as Schedule 5.5 to this Agreement.
(b) Except as set forth in Schedule 5.5, the Financial Statements have
been prepared from the books and records of the Company in accordance with GAAP,
consistently applied (except as may be indicated in the notes thereto and except
for the absence of notes in the Interim Financial Statements) and, except to the
extent set forth in the next succeeding sentence, present fairly the financial
position and results of operations and cash flows of the Company as of the dates
of such statements and for the periods covered thereby. The parties hereto
acknowledge and agree that there may be unrecorded adjustments to the Interim
Financial Statements and that such adjustments (i) will not exceed $5,000 for
any individual line item adjustment or $15,000 in the aggregate for all such
line item adjustments, and (ii) will be in addition to those (a) described
9
<PAGE>
on Schedule 5.5 and (b) those related to the line item entitled Loss on Disposal
of Discontinued Business, net of income taxes, as of December 31, 1997 in the
work papers relating to the Interim financial Statements.
5.6. LIABILITIES AND OBLIGATIONS. Except as set forth in Schedule 5.6, as of the
Balance Sheet Date the Company did not have, nor has it incurred since that
date, any liabilities or obligations (whether absolute, accrued, contingent or
otherwise) except (a) liabilities, obligations or contingencies (i) that are
reflected, accrued or reserved against in the Financial Statements or reflected
in the notes thereto or (ii) that were incurred after the Balance Sheet Date and
were incurred in the ordinary course of business, consistent with past
practices, (b) obligations to perform or pay pursuant to executory arrangements
or agreements, loans, leases or other contracts identified on the schedules
hereto, and (c) liabilities or obligations that would be required to be
disclosed as an exception to a representation or warranty set forth in this
Article V but for the fact that such liabilities or obligations are lower in
amount than the specific dollar thresholds set forth herein. Schedule 5.6 sets
forth the Company's outstanding principal amount of indebtedness for borrowed
money (including overdrafts) as of July 24, 1998.
5.7. ACCOUNTS AND NOTES RECEIVABLE. Schedule 5.7 sets forth an accurate list of
the accounts and notes receivable of the Company as of the Balance Sheet Date
and of those invoiced between the Balance Sheet Date and July 24, 1998,
including any such amounts which are not reflected in the Interim Balance Sheet.
Receivables from and advances to employees, the Stockholders and any entities or
persons related to or Affiliates of the Stockholders are separately identified
in Schedule 5.7. Schedule 5.7 also sets forth an accurate aging of all accounts
and notes receivable as of the Balance Sheet Date, showing amounts due in 30-day
aging categories. The trade and other accounts receivable of the Company,
including without limitation those classified as current assets on the Interim
Balance Sheet, are bona fide receivables, were acquired in the ordinary course
of business, are stated in accordance with GAAP and are collectible in the
amounts shown on Schedule 5.7, net of reserves reflected in the Interim
Financial Statements with respect to the accounts receivable as of the Balance
Sheet Date, and net of reserves reflected in the books and records of the
Company (consistent with the methods used in the Interim Financial Statements)
with respect to receivables of the Company created after the Balance Sheet Date.
5.8. ASSETS.
(a) Schedule 5.8 sets forth an accurate list of all real and tangible
personal property included in "property and equipment" on the Interim Balance
Sheet and all other tangible assets of the Company with a book value in excess
of $10,000 (i) owned by the Company as of the Balance Sheet Date or (ii)
acquired since the Balance Sheet Date. Schedule 5.8 indicates which assets used
in the operation of the business of the Company are currently owned by the
Stockholders or Affiliates of the Company or the Stockholders. Except as
specifically identified in Schedule 5.8, all of the tangible assets, vehicles
and other significant machinery and equipment of the Company listed in Schedule
5.8 are in materially good working order and condition, ordinary wear and tear
excepted. Except as specifically described in Schedule 5.8, all fixed assets
used by the Company in its business are either owned by the Company or leased
10
<PAGE>
under agreements identified in Schedule 5.8. All leases set forth in Schedule
5.8 are in full force and effect and constitute valid and binding agreements of
the Company and to the Knowledge of the Stockholders, the other parties thereto
in accordance with their respective terms. Schedule 5.8 is a true, complete and
correct list of all title reports and title insurance policies received or owned
by the Company.
(b) The Company has good and indefeasible title to the tangible
personal property and the real property owned and used in its business,
including the properties identified in Schedule 5.8 as owned real property, free
and clear of all Encumbrances other than Permitted Encumbrances and those set
forth in Schedule 5.8.
(c) Except as specifically described in Schedule 5.8, the owned
tangible assets of the Company include all the assets owned and used in the
operation of the business of the Company as conducted at the Balance Sheet Date,
except for dispositions of such assets since such date in the ordinary course of
business, consistent with past practices or except as contemplated hereby.
5.9. MATERIAL CUSTOMERS AND CONTRACTS.
(a) Schedule 5.9 sets forth an accurate list of (i) all medical
customers representing 5% or more of the Company's revenues for the fiscal year
ended in 1997 or the interim period ended on the Balance Sheet Date (the
"Material Customers"), and (ii) all material executory contracts, warranties,
commitments and similar agreements to which the Company is currently a party or
by which it or any of its properties is bound, including, but not limited to,
(A) all customer contracts in excess of $10,000, individually, or $25,000 in the
aggregate, including, without limitation, consignment contracts, (B) contracts
with any labor organizations, (C) leases providing for annual rental payments in
excess of $5,000, individually, or $10,000 in the aggregate, (D) loan
agreements, (E) pledge and security agreements, (F) indemnity or guaranty
agreements or obligations, (G) bonds, (H) notes, (I) mortgages, (J) joint
venture or partnership agreements, (K) options to purchase real or personal
property, and (L) agreements relating to the purchase or sale by the Company of
assets (other than oral agreements relating to sales of inventory or services in
the ordinary course of business, consistent with past practices) or securities
for more than $5,000, individually, or $10,000 in the aggregate. Prior to the
date hereof, the Company has made available to BVI complete and correct copies
of all such agreements.
(b) Except to the extent set forth in Schedule 5.9, (i) no Material
Customer has canceled or substantially reduced or, has to the Knowledge of the
Stockholders, threatened to cancel or substantially reduce its purchases of the
Company's products or services, and (ii) the Company is in compliance with all
material commitments and obligations pertaining to it under such agreements and
is not in default under any of the agreements described in subsection (a), no
notice of default has been received by the Company, and the Stockholders and the
Company are aware of no basis therefor.
(c) Except to the extent set forth in Schedule 5.9, the Company is not
a party to any governmental contracts subject to price redetermination or
renegotiation. Schedule 5.9 sets forth
11
<PAGE>
the Company's material bonding or other financial security requirements or
arrangements in connection with any transactions with any of its customers or
suppliers.
(d) Schedule 5.9 sets forth a summary of each outstanding bid or
proposal by the Company that, if awarded to the Company, contemplates payments
to the Company in excess of $100,000 and that is subject to acceptance or award
by a third party.
5.10. PERMITS. Schedule 5.10 contains an accurate list of all licenses,
franchises, permits, transportation authorities and other governmental
authorizations held by the Company, including, without limitation, permits,
licenses and operating authorizations, titles (including motor vehicle titles
and current registrations), fuel permits, franchises and certificates owned or
held by the Company (the "Permits"). The Permits are valid, and the Company has
not received any written notice that any Governmental Authority intends to
cancel, terminate or not renew any such license, operating authorization,
franchise, permit or other governmental authorization. To the Knowledge of the
Stockholders, the Permits are all the permits that are required by Law for the
operation of the business of the Company as conducted at the Balance Sheet Date.
The Company has conducted and is conducting its business in substantial
compliance with the requirements, standards, criteria and conditions set forth
in the Permits, as well as the applicable orders, approvals and variances
related thereto, and is not in violation of any of the foregoing. Except as
specifically provided in Schedule 5.10, the transactions contemplated by this
Agreement will not result in a default under or a breach or violation of, or
adversely affect the rights and benefits afforded to the Company by, any
Permits.
5.11. ENVIRONMENTAL MATTERS. Except as set forth in Schedule 5.11, (a) the
Company has complied with and is in compliance with all Environmental Laws,
including, without limitation, Environmental Laws relating to air, water, land
and the generation, storage, use, handling, transportation, treatment or
disposal of Hazardous Substances; (b) the Company has obtained and complied with
all necessary permits and other approvals necessary for the treatment,
transportation, storage, disposal and other handling by the Company of Hazardous
Substances and with respect to all past and present sites owned or operated by
the Company where Hazardous Substances have been treated, stored, disposed of or
otherwise handled by the Company, there have been no violations of any reporting
obligations under any Environmental Laws so as to create any liability for the
Company; (c) there have been no "releases" or threats of "releases" (as defined
in any Environmental Laws) by the Company at, from, in or on any property owned
or operated by the Company in such form or substance so as to create any
liability for the Company; (d) there is no on-site or off-site location to which
the Company has transported or disposed of Hazardous Substances or arranged for
the transportation or disposal of Hazardous Substances which is the subject of
any federal, state, local or foreign enforcement action or any other
investigation which could lead to any claim against the Surviving Corporation,
BVI or Newco for any clean-up cost, remedial work, damage to natural resources
or personal injury, including, but not limited to, any claim under (i) the
Comprehensive Environmental Response, Compensation and Liability Act of 1980, as
amended, (ii) the Resource Conservation and Recovery Act, (iii) the Hazardous
Materials Transportation Act, or (iv) comparable state and local statutes and
regulations; and (e) the Company has no contingent liability in connection with
any release or disposal by the Company of any Hazardous Substance into the
environment. None of the past or present sites owned or operated by the Company
is
12
<PAGE>
currently or has ever been designated as a treatment, storage and/or disposal
facility pursuant to 42 U.S.C. ss. 6925 as a result of any actions taken by the
Company, nor has the Company ever applied for a Permit designating any such
facility as a treatment, storage and/or disposal facility pursuant to 42 U.S.C.
ss. 6925. To the Knowledge of the Stockholders, except as set forth in Schedule
5.11, (a) with respect to all past and present sites owned or operated by the
Company where Hazardous Substances have been treated, stored, disposed of or
otherwise handled by third parties, there have been no violations of any
reporting obligations under any Environmental Laws so as to create any liability
for the Company, (b) there have been no "releases" or threats of "releases" by
third parties at, from, in or on any property owned or operated by the Company
in such form or substance so as to create any liability for the Company, (c) the
Company has no contingent liability in connection with any release or disposal
by any third party of any Hazardous Substance into the environment, and (d) none
of the past or present sites owned or operated by the Company is currently or
has ever been designated as a treatment, storage and/or disposal facility
pursuant to 42 U.S.C. ss. 6925 as a result of any actions taken by any third
party, nor has any third party ever applied for a Permit designating any such
facility as a treatment, storage, and/or disposal facility pursuant to 42 U.S.C.
ss. 6925.
5.12. LABOR AND EMPLOYEE RELATIONS. Except as set forth in Schedule 5.12, the
Company is not bound by or subject to any arrangement with any labor union.
Except as set forth in Schedule 5.12, no employees of the Company are
represented by any labor union or covered by any collective bargaining agreement
nor is any campaign to establish such representation in progress. There is no
pending or, to the Knowledge of the Stockholders, threatened labor dispute
involving the Company and any group of its employees nor has the Company
experienced any significant labor interruptions since November 1, 1994.
5.13. INSURANCE. Schedule 5.13 sets forth an accurate list as of the Balance
Sheet Date of all insurance policies carried by the Company and of insurance
loss runs since February 25, 1997 and workmen's compensation claims since
November 1, 1994. Except as set forth in Schedule 5.13, all of such policies are
"claims made" policies. The policies listed in such Schedule are currently in
full force and effect.
5.14. COMPENSATION; EMPLOYMENT AGREEMENTS. Schedule 5.14 sets forth an accurate
schedule of all officers, directors and employees of the Company with annual
compensation of $50,000 or more, listing the rate of compensation (and the
portions thereof attributable to salary and bonus), and, to the extent not
generally made available to all employees of the Company, other benefits and
other compensation, respectively of each of such persons as of (a) the Balance
Sheet Date and (b) July 24, 1998. Schedule 5.14 sets forth a true, complete and
correct list of each employment or consulting agreement between the Company and
any employee of the Company or any Stockholder.
5.15. NONCOMPETITION, CONFIDENTIALITY AND NONSOLICITATION AGREEMENTS. Schedule
5.15 sets forth a true, complete and correct list of all agreements containing
covenants not to compete or solicit employees or to maintain the confidentiality
of information to which the Company is bound or under which the Company has any
rights or obligations.
13
<PAGE>
5.16. EMPLOYEE BENEFIT PLANS.
(a) Schedule 5.16 sets forth an accurate schedule of each "employee
benefit plan," as defined in Section 3(3) of the Employee Retirement Income
Security Act of 1974, as amended ("ERISA"), and all nonqualified deferred
compensation arrangements, whether formal or informal and whether legally
binding or not, covering any present or former director, officer or employee of
the Company under which the Company has any current or future obligation or
liability or under which any present or former director, officer or employee of
the Company, or such present or former director's, officer's or employee's
dependents or beneficiaries, has any current or future right to benefits (each
such plan and arrangement referred to hereinafter as a "Plan"). Except as set
forth in Schedule 5.16, the Company does not sponsor, maintain or contribute
currently, or at any time since November 1, 1994, to any plan, program, fund or
arrangement that constitutes an employee pension benefit plan. Each Plan may be
terminated by the Company, at any time without any liability, cost or expense,
other than costs and expenses that are customary in connection with the
termination of a Plan. For purposes of this Agreement, the term "employee
pension benefit plan" shall have the meaning given that term in Section 3(2) of
ERISA.
(b) Each Plan listed in Schedule 5.16 is in compliance in all material
respects with the applicable provisions of ERISA, the Code, the Public Health
Service Act and any other applicable Law. Except as set forth in Schedule 5.16,
with respect to each Plan of the Company (other than a "multiemployer plan," as
defined in Section 4001(a)(3) of ERISA), all reports and other documents
required under ERISA or other applicable Law to be filed with any Governmental
Authority, the failure of which to file could reasonably be expected to result
in a liability to the Company, or required to be distributed to participants or
beneficiaries, have been duly and timely filed or distributed. True and complete
copies of all such reports and other documents with respect to the past three
years for each Plan have been provided to BVI. No "accumulated funding
deficiency" (as defined in Section 412(a) of the Code) with respect to any Plan
has been incurred (without regard to any waiver granted under Section 412 of the
Code), nor has any funding waiver from the Internal Revenue Service been
received or requested. Except as set forth in Schedule 5.16, each Plan that is
intended to be "qualified" within the meaning of Section 401(a) of the Code (a
"Qualified Plan") is, and has been during the period from its adoption to the
date hereof, so qualified, both as to form and operation and all necessary
approvals of Governmental Authorities, including a favorable determination as to
the qualification under the Code of each of such Qualified Plans and each
amendment thereto, have been timely obtained. Except as set forth in Schedule
5.16, all accrued contribution obligations of the Company with respect to any
Plan have either been fulfilled in their entirety or are fully reflected in the
Financial Statements.
(c) No Plan has incurred or will incur, and the Company has not
incurred and will not incur with respect to any Plan, any liability for excise
tax or penalty due to the Internal Revenue Service. There have been no
terminations, partial terminations or discontinuances of contributions to any
Qualified Plan since November 1, 1994 without notice to and approval by the
Internal Revenue Service and payment of all obligations and liabilities
attributable to such Qualified Plan.
14
<PAGE>
(d) Except as set forth in Schedule 5.16, the Company has not made any
promises of retirement or other benefits to employees, except as set forth in
the Plans, and the Company neither maintains nor has established any Plan that
is a "welfare benefit plan" within the meaning of Section 3(1) of ERISA that
provides for retiree medical benefits or any other continuing benefits or
coverage for any participant or any beneficiary of a participant after such
participant's termination of employment, except as may be required by Part 6 of
Subtitle B of Title I of ERISA and Section 4980B of the Code and similar state
Law provisions, and at the expense of the participant or the beneficiary of the
participant. The Company neither maintains, has established nor has ever
participated in a multiple employer welfare benefit arrangement as described in
Section 3(40)(A) of ERISA. Except as set forth in Schedule 5.16, the Company has
no current or future obligation or liability with respect to a Plan pursuant to
the provisions of a collective bargaining agreement.
(e) The Company has not incurred any material liability to the Pension
Benefit Guaranty Corporation in connection with any Plan. The assets of each
Plan that are subject to Title IV of ERISA are sufficient to provide the
benefits under such Plan, the payment of which the Pension Benefit Guaranty
Corporation would guarantee if such Plan were terminated, and such assets are
also sufficient to provide all other "benefits liabilities" (as defined in ERISA
Section 4001(a)(16)) due under such Plan upon termination.
(f) No "reportable event" (as defined in Section 4043 of ERISA) has
occurred and is continuing with respect to any Plan subject to Title IV of
ERISA. There are no pending claims, lawsuits or actions (other than routine
claims for benefits in the ordinary course) asserted or instituted against, and
to the Knowledge of the Stockholders there are no threatened litigation or
claims against, the assets of any Plan or its related trust or against any
fiduciary of a Plan with respect to the operation of such Plan. There are no
investigations or audits of any Plan by any Governmental Authority currently
pending and there have been no such investigations or audits that have been
concluded that resulted in any liability to the Company that has not been fully
discharged. The Company has not participated in any voluntary compliance or
closing agreement programs established with respect to the form or operation of
a Plan.
(g) The Company has not engaged in any prohibited transaction, within
the meaning of Section 406 of ERISA or Section 4975 of the Code, in connection
with any Plan for which exemption was not available. Except as set forth in
Schedule 5.16, the Company neither is, nor ever has been, a participant in or is
obligated to make any payment to a multiemployer plan. No person or entity that
was engaged by the Company as an independent contractor since November 1, 1994
reasonably can or will be characterized or deemed to be an employee of the
Company under applicable Laws for any purpose whatsoever, including, without
limitation, for purposes of federal, state and local income taxation, workers'
compensation and unemployment insurance and Plan eligibility.
(h) The Company has no liability or obligation with respect to any plan
or program maintained by any ERISA Affiliate which would be a Plan if it were
maintained by the Company for its employees. For purposes of this subsection
(h), the term "ERISA Affiliate" means any
15
<PAGE>
corporation or trade or business under common control with the Company as
determined under Section 414(b), (c), (m) or (o) of the Code.
5.17. LITIGATION AND COMPLIANCE WITH LAW. Except as set forth in Schedule 5.17,
there are no claims, actions, suits or proceedings, pending or to the Knowledge
of the Stockholders, threatened against or affecting the Company, at law or in
equity, or before or by any Governmental Authority having jurisdiction over the
Company. Except to the extent set forth in Schedule 5.17, the Company has
conducted and is conducting its business in compliance with all Laws applicable
to the Company, its assets or the operation of its business, except where such
noncompliance would not have a material adverse effect upon the financial
condition, operations, results of operations or business of the Company.
5.18. TAXES. For purposes of this Agreement, the term "Taxes" shall mean all
taxes, charges, fees, levies or other assessments including, without limitation,
income, gross receipts, excise, property, sales, withholding, social security,
unemployment, occupation, use, service, service use, license, payroll,
franchise, transfer and recording taxes, fees and charges, imposed by the United
States or any state, local or foreign government or subdivision or agency
thereof, whether computed on a separate, consolidated, unitary, combined or any
other basis; and such term shall include any interest, fines, penalties or
additional amounts attributable to or imposed with respect to any such taxes,
charges, fees, levies or other assessments. The Company has timely filed all
requisite federal, state, local and other tax returns for all fiscal periods
ended on or before the Closing, and has duly paid in full or made adequate
provision in the Financial Statements for the payment of all Taxes for all
periods ending at or prior to the Balance Sheet Date and has duly paid in full
or made adequate provision in the books and records of the Company for the
payment of all Taxes for all periods commencing after the Balance Sheet Date and
ending at or prior to the Closing Date. The Company has duly withheld and paid
or remitted all Taxes required to have been withheld and paid in connection with
amounts paid or owing to any employee, independent contractor, creditor,
shareholder or other person or entity that required withholding under any
applicable Law, including, without limitation, any amounts required to be
withheld or collected with respect to social security, unemployment
compensation, sales or use taxes or workers' compensation. Except as set forth
in Schedule 5.18, the Company has not received any notification of any
examinations in progress relating to taxes for any period prior to the Closing.
To the Knowledge of the Stockholders, there are no claims against the Company
relating to Taxes for any period or periods prior to and including the Balance
Sheet Date. No written notice of any claim for Taxes, whether pending or
threatened, has been received. The Company has not granted or been requested to
grant any extension of the limitation period applicable to any claim for Taxes
or assessments with respect to Taxes. The Company is not a party to any Tax
allocation or sharing agreement and is not otherwise liable or obligated to
indemnify any person or entity with respect to any Taxes. The amounts shown as
accruals for Taxes on the Interim Financial Statements as of the Balance Sheet
Date are sufficient for the payment of all Taxes for all fiscal periods ended on
or before that date. True and complete copies of (a) any tax examinations, (b)
extensions of statutory limitations and (c) the federal, state and local Tax
returns of the Company for the last three fiscal years have been previously
provided to BVI. There are no requests for ruling in respect of any Tax pending
between the Company and any Taxing authority. The Company currently utilizes the
accrual method of accounting for income tax purposes. Such method of accounting
has not changed since November 1, 1994.
16
<PAGE>
5.19. ABSENCE OF CHANGES. Since the Balance Sheet Date, except as set forth in
Schedule 5.19 and except as contemplated by this Agreement, the Company has
conducted its operations in the ordinary course and there has not been:
(a) any material adverse change in the business, operations,
properties, condition (financial or other), assets, liabilities (contingent or
otherwise), results or prospects of the Company;
(b) any damage, destruction or loss (whether or not covered by
insurance) adversely affecting the properties or business of the Company,
individually or in the aggregate;
(c) any change in the authorized capital stock of the Company or in its
outstanding securities or any grant by the Company of any options, warrants,
calls, conversion rights or commitments;
(d) any declaration or payment of any dividend or distribution in
respect of the capital stock or any direct or indirect redemption, purchase or
other acquisition of any of the capital stock of the Company by the Company;
(e) any increase in the compensation payable or to become payable by
the Company to the Stockholders or any of its officers, directors, employees,
consultants or agents, except for ordinary and customary bonuses and salary
increases for employees in accordance with past practice, which bonuses and
salary increases are set forth in Schedule 5.19;
(f) any significant work interruptions, labor grievances or claims
filed;
(g) any sale or transfer, or any agreement to sell or transfer, any
assets, properties or rights of the Company to any person, including, without
limitation, the Stockholders and their Affiliates outside of the ordinary course
of the Company's business;
(h) any cancellation, or agreement to cancel, any indebtedness or other
obligation owing to the Company;
(i) any increase in the Company's indebtedness, other than accounts
payable incurred in the ordinary course of business, consistent with past
practices or incurred in connection with the transactions contemplated by this
Agreement;
(j) any plan, agreement or arrangement granting any preferential rights
to purchase or acquire any interest in any of the assets, property or rights of
the Company or requiring consent of any party to the transfer and assignment of
any such assets, property or rights;
(k) any purchase or acquisition of, or agreement, plan or arrangement
to purchase or acquire, any property, rights or assets outside of the ordinary
course of the Company's business;
17
<PAGE>
(l) any waiver of any rights or claims of the Company;
(m) any breach, amendment or termination of any contract, agreement,
Permit or other right to which the Company is a party or any of its property is
subject; or
(n) any other transaction by the Company outside the ordinary course of
business.
5.20. ACCOUNTS WITH BANKS AND BROKERAGES; POWERS OF ATTORNEY. Schedule 5.20 sets
forth an accurate schedule as of July 24, 1998, of (a) the name of each
financial institution or brokerage firm in which the Company has accounts or
safe deposit boxes; (b) the names in which the accounts or boxes are held; (c)
the type of account and the cash, cash equivalents and securities held in such
account as of July 24, 1998, none of which assets have been withdrawn from such
accounts since July 24, 1998 except for bona fide business purposes in the
ordinary course of the business of the Company; and (d) the name of each person
authorized to draw thereon or have access thereto. Schedule 5.20 also sets forth
the name of each person, corporation, firm or other entity holding a general or
special power of attorney from the Company and a description of the terms
thereof.
5.21. ABSENCE OF CERTAIN BUSINESS PRACTICES. Neither the Company nor any of its
Affiliates has given or offered to give anything of value to any governmental
official, political party or candidate for government office nor has it
otherwise taken any action which would constitute a violation of the Foreign
Corrupt Practices Act of 1977, as amended, or any similar Law.
5.22. RESERVED.
5.23. INTANGIBLE PROPERTY. Schedule 5.23 sets forth an accurate list of all
patents, patent applications, trademarks, service marks, technology, licenses,
trade names, registered copyrights and other intellectual property or
proprietary property rights owned or used by the Company. To the Knowledge of
the Stockholders, the Company owns or possesses, and the assets of the Company
include, sufficient legal rights to use all of such items without conflict with
or infringement of the rights of others.
5.24. TAX REORGANIZATION REPRESENTATION. The Surviving Corporation will acquire
substantially all of the properties of the Company within the meaning of Section
368(a)(2)(D) of the Code.
5.25. RESERVED.
5.26. INVENTORY. Except as set forth in Schedule 5.26, the inventory of the
Company on the Closing Date (the "Inventory") represents the normal supplies and
stock and trade of Company on hand as of the close of business on the Closing
Date. Except to the extent reserved against in the Financial Statements and the
books and records of the Company, the Inventory will be as of the Closing Date,
good, merchantable and saleable at customary prices in the ordinary course of
business and is and will be, as of the Closing Date, of a quality, quantity and
mix consistent with Company's past business practices and demands of its
customers. Any obsolete inventory has
18
<PAGE>
been properly reserved to reflect its net realizable value in the Financial
Statements or the books and records of the Company.
5.27. PRODUCT LIABILITY CLAIMS. All products which Company has sold have been
merchantable and free from material defects in material or workmanship under the
conditions set forth in the Company's applicable standard written limited
product warranties. Except as set forth on Schedule 5.27, during the last three
(3) years the Company has not received any claim based upon an alleged breach of
product warranty arising from Company's sale of its products (hereinafter
collectively referred to as "Product Liability Claims"). Company has no
reasonable grounds to believe that future Product Liability Claims with respect
to products of Company sold prior to the Closing Date will result in losses or
damages payable by the Company which will be in excess of Company's past
experience with respect thereto as set forth herein.
5.28. YEAR 2000 COMPLIANCE. Schedule 5.28 is a true, complete and correct list
of all computer software, firmware and hardware and other related business
systems, equipment or operations used by the Company. Schedule 5.28 describes
all actions taken by the Company to address potential Year 2000 problems.
5.29. WARRANTY OF PRODUCTS. The Company has not made or given any express
warranty or guaranty with respect to any products manufactured or sold by the
Company except as set forth in Schedule 5.29.
5.30. ISO-9002. Except as set forth on Schedule 5.30, all products manufactured
by the Company have been manufactured in accordance with ISO-9002. The Company
has retained all documents necessary for compliance with ISO-9002.
5.31. INDIVIDUAL REPRESENTATIONS AND WARRANTIES OF THE STOCKHOLDERS. In
connection with and as an inducement to BVI to enter into and be bound by the
terms of this Agreement, each Stockholder in his or her individual capacity
severally represents and warrants to BVI as follows:
(a) AUTHORIZATION; NON-CONTRAVENTION; APPROVALS
(i) Such Stockholder has the full legal right, power and authority
to enter into this Agreement.
(ii) The execution and delivery of this Agreement by such
Stockholder does not, and the consummation by such Stockholder of
the transactions contemplated hereby will not, violate or result in
a breach of any provision of, or constitute a default (or an event
which, with notice or lapse of time or both, would constitute a
default) under, or result in the termination of, or accelerate the
performance required by, or result in a right of termination or
acceleration under, (a) any Laws applicable to such Stockholder, or
(b) except as set forth in Schedule 5.31(a), any note, bond,
mortgage, indenture, deed of trust, license, franchise, permit,
concession, lease or other instrument, obligation or agreement of
any kind to which such Stockholder is now a party.
19
<PAGE>
(iii) This Agreement has been duly and validly executed and
delivered by such Stockholder, and, assuming the due authorization,
execution and delivery hereof by BVI and Newco, constitutes a valid
and binding agreement of such Stockholder, enforceable against such
Stockholder in accordance with its terms, except as enforceability
may be limited by bankruptcy, insolvency, reorganization,
moratorium or other similar laws relating to or affecting
creditors' rights or by general equitable principles (regardless of
whether such enforceability is considered in a proceeding in equity
or at law.)
(iv) Except as set forth in Schedule 5.31(a), no declaration,
filing or registration with, or notice to, or authorization,
consent or approval of, any Governmental Authority or third party
is necessary for the execution and delivery of this Agreement by
such Stockholder or the consummation by such Stockholder of the
transactions contemplated hereby.
(b) STOCK OWNERSHIP. Such Stockholder owns beneficially and of record
the Shares set forth opposite such Stockholder's name on Schedule 5.31(b) free
and clear of all liens, encumbrances, restrictions and claims of every kind
(except encumbrances resulting from restrictions on transferability imposed by
federal and state securities laws).
(c) CAPITALIZATION. Except as set forth in Schedule 5.31(c), no
subscription, option, warrant, call, convertible or exchangeable security, other
conversion right or commitment of any kind exists which obligates such
Stockholder to transfer any of the capital stock of the Company.
(d) ABSENCE OF CHANGES. Except as set forth in Schedule 5.31(d), since
the Balance Sheet Date, there has not been any change in such Stockholder's
ownership interest in the Company or any grant by such Stockholder of any
options, warrants, calls, conversion rights or commitments.
(e) COMPETING LINE OF BUSINESS; RELATED PARTY TRANSACTION. Except as
set forth in Schedule 5.31(e), and except for any equity interest of less than
1% owned by Willard and Catherine Sykes in any entity neither such Stockholder
nor, to the actual knowledge of such Stockholder, any other Affiliate of the
Company owns, directly or indirectly, any interest in, or is an officer,
director, employee or consultant of or otherwise receives remuneration from, any
business which is in the Business or is a lessor, lessee, customer or supplier
of the Company. Except as set forth in Schedule 5.31(e) such Stockholder does
not have and, to the actual knowledge of such Stockholder, no officer or
director of the Company or any other Stockholder has, any interest in any
property, real or personal, tangible or intangible, used in or pertaining to the
business of the Company.
(f) Such Stockholder (i) has voted his or her shares of the Company
Common Stock in favor of the Merger or approved the Merger pursuant to a written
action in accordance with the MBA, (ii) has not filed any notice with the
Company pursuant to Minnesota Statutes, Section 302A.473 electing to exercise
his or her dissenter's rights thereunder, and (iii) has waived such dissenter's
rights as a result of executing a written action.
20
<PAGE>
5.32. INDIVIDUAL REPRESENTATIONS AND WARRANTIES OF JAMES PFAU. In connection
with and as an inducement to BVI to enter into and be bound by the terms of this
Agreement, James Pfau ("Pfau") in his individual capacity represents and
warrants to BVI as follows:
(a) STOCK OWNERSHIP. To the actual knowledge of Pfau, each Stockholder
owns beneficially and of record the shares of the Company Common Stock set forth
opposite each Stockholder's name on Schedule 5.32(a) free and clear of all
liens, encumbrances, restrictions and claims of every kind (except for
encumbrances resulting from restrictions on transferability imposed by federal
and state securities laws).
(b) CAPITALIZATION. Except as set forth in Schedule 5.32, to the actual
knowledge of Pfau, no subscription, option, warrant, call, convertible or
exchangeable security, other conversion right or commitment of any kind exists
which obligates any Stockholder to transfer any of the capital stock of the
Company.
5.33. DISCLOSURE. The Stockholders and the Company have provided BVI or its
representatives all the information that BVI has requested in analyzing whether
to consummate the Merger and the other transactions contemplated by this
Agreement. No representation or warranty of the Stockholders to BVI or Newco in
this Agreement contains any untrue statement of a material fact or omits to
state a material fact necessary in order to make the statements herein, in light
of the circumstances under which they were made, not misleading.
ARTICLE VI
REPRESENTATIONS AND WARRANTIES OF BVI AND NEWCO
BVI and Newco jointly and severally represent and warrant to the Stockholders as
follows:
6.1. ORGANIZATION. Each of BVI and Newco is a corporation duly organized,
validly existing and in good standing under the Laws of the State of Minnesota,
and is duly authorized and qualified under all applicable Laws to carry on its
business in the places and in the manner now conducted. Each of BVI and Newco
has the requisite power and authority to own, lease and operate its assets and
properties and to carry on its business as such business is currently being
conducted. True, complete and correct copies of the Articles of Incorporation
and Bylaws, each as amended, of each of BVI and Newco have been previously
delivered to counsel for the Company.
6.2. AUTHORIZATION; NON-CONTRAVENTION; APPROVALS.
(a) Each of BVI and Newco has the requisite power and authority to
enter into this Agreement, to perform its obligations hereunder and to
consummate the transactions contemplated hereby. The execution, delivery and
performance of this Agreement has been approved by the boards of directors of
BVI and Newco, and BVI, as the sole stockholder of Newco. No additional
corporate proceedings on the part of BVI or Newco are necessary to authorize the
execution and delivery of this Agreement and the consummation by BVI and Newco
of the transactions contemplated hereby. This Agreement has been duly and
validly executed and delivered by BVI and Newco, and, assuming the due
authorization, execution and
21
<PAGE>
delivery by the Company and the Stockholders, constitutes valid and binding
agreements of BVI and Newco, enforceable against BVI and Newco in accordance
with its terms, except as enforceability may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws relating to or
affecting creditors' rights or by general equitable principles (regardless of
whether such enforceability is considered in a proceeding in equity or at law.).
(b) The execution and delivery of this Agreement by BVI and Newco do
not, and the consummation by BVI and Newco of the transactions contemplated
hereby will not, conflict, violate or result in a breach of any provision of, or
constitute a default (or an event which, with notice or lapse of time or both,
would constitute a default) under, or result in the termination of, or
accelerate the performance required by, or result in a right of termination or
acceleration under any of the terms, conditions or provisions of (i) the
Articles of Incorporation or By-Laws of BVI or Newco, (ii) any Law applicable to
either BVI or Newco or any of its properties or assets or (iii) any note, bond,
mortgage, indenture, deed of trust, license, franchise, permit, concession,
contract, lease or other instrument, obligation or agreement of any kind to
which BVI or Newco is now a party or by which either BVI or Newco or any of
their properties or assets may be bound or affected.
(c) Except for the Merger Filing and such filings as are required under
federal or state securities Laws, no declaration, filing or registration with,
or notice to, or authorization, consent or approval of, any Governmental
Authority, court or other third party is necessary for the execution and
delivery of this Agreement by BVI and Newco or the performance of and
consummation by BVI and Newco of the transactions contemplated hereby.
6.3. BVI SECURITIES. The shares of BVI Common Stock to be issued to each
Stockholder pursuant to the Merger are duly authorized and, when issued in
accordance with the terms of this Agreement, will be validly issued, fully paid
and nonassessable and free and clear of all Encumbrances, except for any
Encumbrances created by the Stockholders and encumbrances resulting from
restrictions on transferability imposed by federal and state securities laws.
Upon delivery to the Stockholders of the certificates evidencing the Restricted
Shares, the Stockholders shall acquire valid title to the Restricted Shares.
6.4. TAX REORGANIZATION REPRESENTATIONS.
(a) Prior to the Merger, BVI will be in control of Newco within the
meaning of Section 368(c) of the Code.
(b) BVI has no plan or intention to cause the Surviving Corporation to
issue additional shares of its stock that would result in BVI losing control of
the Surviving Corporation within the meaning of Section 368(c) of the Code.
(c) BVI has no plan or intention to reacquire any of its stock issued
in the Merger.
(d) BVI has no plan or intention to liquidate the Surviving
Corporation; to merge the Surviving Corporation with or into another
corporation; to sell or otherwise dispose of the stock
22
<PAGE>
of the Surviving Corporation except for transfers of stock to another
corporation controlled by BVI; or to cause the Surviving Corporation to sell or
otherwise dispose of any of its assets, except for dispositions made in the
ordinary course of business or transfers of assets to a corporation controlled
by BVI.
(e) Following the Closing, BVI's intention is that the Surviving
Corporation will continue the historic business of the Company or use a
significant portion of the historic business assets of the Company in a
business, all as required to satisfy the "continuity of business enterprise"
requirement under Section 368 of the Code.
(f) BVI does not own, nor has it owned during the past five years, any
shares of the stock of the Company.
(g) Each of BVI and Newco is undertaking the Merger for a bona fide
business purpose and not merely for the avoidance of federal income tax.
(h) Neither BVI nor Newco is an investment company as defined in
Section 368(a)(2)(F)(iii) and (iv) of the Code.
(i) As of the Closing Date but prior to the Effective Time, the fair
market value of the assets of Newco will exceed the sum of Newco's liabilities
plus the amount of other liabilities, if any, to which Newco's assets are
subject.
(j) No Newco stock will be given as consideration in connection with
the transaction.
6.5. SEC FILINGS. BVI has filed with the SEC all material forms, statements,
reports and documents required to be filed by it prior to the date hereof under
each of the 1933 Act, the 1934 Act, and the respective rules and regulations
thereunder, (a) all of which, as amended, if applicable, complied when filed in
all material respects with all applicable requirements of the applicable Act and
the rules and regulations thereunder, and (b) none of which, as amended, if
applicable, including any financial statements or schedules included therein,
contains any untrue statement of material fact or omits to state a material fact
required to be stated therein or necessary in order to make the statements made
therein, in the light of the circumstances under which they were made, not
misleading. True and correct copies of the forms, statements, reports and
documents filed by BVI with the SEC since November 1, 1997 (the "BVI SEC
Reports") have been furnished to the Stockholders. The consolidated statements
of financial position and the related consolidated statements of income,
shareholders' equity and cash flows (including the related notes thereto) of BVI
included in the BVI SEC Reports (the "BVI Financial Statements") complied as to
form in all material respects with applicable accounting requirements and the
rules and regulations of the SEC with respect thereto, are in accordance with
the books and records of BVI, have been prepared in accordance with GAAP applied
on a basis consistent with prior periods, and present fairly the consolidated
financial position of BVI and its subsidiaries as of their respective dates, and
the consolidated results of their operations and their cash flows for the
periods presented therein. The authorized capital stock of BVI is as set forth
in the BVI SEC Reports.
23
<PAGE>
6.6. DISCLOSURE. BVI has fully provided the Stockholders or their
representatives with all the information that the Stockholders have requested in
analyzing whether to consummate the Merger. None of the information so provided
nor any representation or warranty of BVI contained in this Agreement contains
any untrue statement of a material fact or omits to state a material fact
necessary in order to make the statements herein or therein, in light of the
circumstances under which they were made, not misleading.
6.7. NO MATERIAL ADVERSE CHANGE. Except as disclosed in the BVI SEC Reports and
except for the transactions contemplated hereby, since October 31, 1997, the
business of BVI has been carried on in the ordinary and usual course, and
neither BVI nor any of its subsidiaries has sustained since October 31, 1997 any
material loss or interference with its business from fire, explosion, flood or
other calamity, whether or not covered by insurance, or from any labor dispute
or court or government action, order or decree, and since October 31, 1997 there
has not been any material change or, to the actual knowledge of BVI, any
development involving a prospective material change, in the business,
operations, results of operations or financial condition of BVI and its
subsidiaries (actual knowledge of BVI shall mean, for purposes of this Section
6.7, the actual knowledge of all the executive officers of BVI).
6.8. NO PROCEEDINGS. There are no legal or governmental proceedings pending to
which BVI or any of its subsidiaries is a party or of which any property of BVI
or any of its subsidiaries is the subject, other than as set forth in the
reports filed by BVI under the 1934 Act and other than litigation or
governmental proceedings incident to the kind of business conducted by BVI and
its subsidiaries which, if determined adversely to BVI and its subsidiaries,
would not individually or in the aggregate have a material adverse effect on the
business, operations, results of operations, or financial position of BVI and
its subsidiaries; and to the knowledge of BVI and Newco, no such proceedings are
threatened by governmental authorities or threatened by others.
6.9. OWNERSHIP OF NEWCO; NO PRIOR ACTIVITIES. Newco was formed solely for the
purpose of engaging in the transactions contemplated hereby. As of the date
hereof and the Effective Time, the capital stock of Newco is and will be owned
100% by BVI directly. Further, there are not as of the date hereof and there
will not be at the Effective Time any outstanding or authorized options,
warrants, calls, commitments or any other agreements of any character which
Newco is a party to, or may be bound by, requiring it to issue, transfer, sell,
purchase, redeem or acquire any shares of capital stock or any securities or
rights convertible into, exchangeable for, or evidencing the right to subscribe
for or acquire, any shares of capital stock of Newco. As of the date hereof and
the Effective Time, except for obligations or liabilities incurred in connection
with its incorporation or organization and the transactions contemplated hereby,
Newco has not and will not have incurred, directly or indirectly through any
subsidiary or Affiliate, any obligations or liabilities or engaged in any
business or activities of any type or kind whatsoever or entered into any
agreements or arrangements with any person or entity. BVI will take all action
necessary to ensure that Newco at no time prior to the Effective Time owns any
asset other than an amount of cash necessary to incorporate Newco and to pay the
expenses of the Merger attributable to Newco in connection with the Merger.
24
<PAGE>
ARTICLE VII
CERTAIN COVENANTS
7.1 FUTURE COOPERATION; TAX MATTERS. Each of the Stockholders and BVI shall each
deliver or cause to be delivered to the other following the Closing such
additional instruments as the other may reasonably request for the purpose of
fully carrying out this Agreement. Each of the Stockholders will cooperate with
BVI and the Surviving Corporation at and after the Closing in furnishing
information, evidence, testimony and other assistance in connection with any
actions, proceedings, arrangements or disputes of any nature with respect to
matters pertaining to all periods prior to the Closing. Each of the Stockholders
will cooperate with the Surviving Corporation in the preparation of all tax
returns covering the period from the beginning of the Company current tax year
through the Closing. In addition, BVI will provide the Stockholders with access
to such of its books and records as may be reasonably requested by the
Stockholders in connection with federal, state and local tax matters relating to
periods prior to the Closing. The party requesting cooperation, information or
actions under this Section 7.1 shall reimburse the other party for all
reasonable out-of-pocket costs and expenses paid or incurred in connection
therewith, which costs and expenses shall not, however, include per diem charges
for employees or allocations of overhead charges.
7.2. EXPENSES. BVI will pay the fees, expenses and disbursements of BVI and its
agents, representatives, accountants and counsel incurred in connection with the
execution, delivery and performance of this Agreement and any amendments
thereto. The Surviving Corporation following the Closing will pay any expenses
of audit or audit related procedures in connection with the transactions
contemplated hereby. The Stockholders will pay only their fees, expenses and
disbursements and those of their and the Company's agents, representatives,
financial advisors, accountants and counsel incurred in connection with the
execution, delivery and performance of this Agreement and any amendments hereto
and the consummation of the transactions contemplated hereby, provided, however,
that BVI and Newco acknowledge and agree that the Company will pay up to $25,000
in expenses incurred by the Company and/or the Stockholders related to the
transaction contemplated hereby.
7.3. LEGAL OPINIONS.
(a) At the Closing, the Company and the Stockholders shall cause their
legal counsel, Faegre & Benson, LLP, to deliver to BVI a legal opinion in form
and substance acceptable to BVI.
(b) At the Closing, BVI and Newco shall cause their legal counsel,
Winthrop & Weinstine, P.A. to deliver to the Company and the Stockholders a
legal opinion in form and substance acceptable to the Company and the
Stockholders. The Company and the Stockholders shall also have received an
opinion, dated the Closing Date, of Winthrop & Weinstine, P.A. to the effect
that the Merger will be treated for Federal income tax purposes as a
reorganization within the meaning of Section 368 of the Code, and that,
accordingly, (i) no gain or loss will be recognized to the Stockholders upon the
exchange of their Company Common Stock for BVI Common Stock pursuant to the
Merger, except to the extent of any "boot" received by any Stockholder, (ii) the
basis of BVI Common Stock received pursuant to the Merger will be the
25
<PAGE>
same as the basis of the Company Common Stock surrendered in exchange therefor,
except to the extent that such basis is adjusted by the receipt of any "boot,"
and (iii) the holding period of BVI Common Stock received pursuant to the Merger
will include the period during which the Company Common Stock was held if a
Stockholder held Company Common Stock as a capital asset on the date of the
exchange.
(c) Each of BVI, Newco, the Company and the Stockholders will provide
Winthrop & Weinstine, P.A. representations reasonably requested by them in
connection with their providing the opinion referred to in Section 7.3(b).
7.4. EMPLOYMENT AGREEMENTS. Concurrently with the execution of this Agreement,
the Surviving Corporation shall enter into a mutually acceptable Employment
Agreement with each of the individuals identified on Schedule 7.4 (collectively,
the "Employment Agreements") and to the extent provided for in the Employment
Agreements, BVI shall guarantee the obligations of the Surviving Corporation
under the Employment Agreements.
7.5. REPAYMENT OF RELATED PARTY INDEBTEDNESS AND REAFFIRMATION OF LEASES.
Immediately after the consummation of the Merger contemplated herein, (a) each
of the Stockholders shall repay to the Company all amounts outstanding as
advances to or receivables from such Stockholder, each of which advances or
receivables is specifically reflected in Schedule 5.7, and (b) the Company shall
repay all amounts outstanding under loans to the Company from any Stockholder or
his or her Affiliates, each of which loans to the Company is specifically
reflected in Schedule 5.6. Further, BVI agrees to cause the Surviving
Corporation to reaffirm those certain lease(s) by and between the Company and
Data Sales Co., Inc. listed on Schedule 5.9 in accordance with their existing
terms provided such reaffirmation shall not extend the term of said leases or
modify any terms or conditions of said leases.
7.6. REGISTRATION STATEMENT ON FORM S-3.
(a) As soon as reasonably practicable after the Closing (but without
obligation to do so earlier than September 11, 1998), BVI shall file with the
SEC a Registration Statement on Form S-3 or any successor short-form
registration statement promulgated by the SEC ("Registration Statement") to
register the resale by the Stockholders of the Registrable Securities under the
1933 Act. After the Registration Statement is filed, BVI shall use reasonable
best efforts to (i) have the Registration Statement declared effective by the
SEC, (ii) thereafter prepare and file, as BVI shall determine may be required
under the 1933 Act and the rules and regulations thereunder, a prospectus
supplement or supplements to the prospectus contained in the Registration
Statement or a post-effective amendment or amendments to the Registration
Statement and, with respect to any post-effective amendment, cause such
post-effective amendment to be declared effective by the SEC, (iii) maintain the
effectiveness of the Registration Statement until the earlier of (A) the date
two years from the date of effectiveness of the Registration Statement, or (B)
the sale of all of the Registrable Securities pursuant to the Registration
Statement. BVI further agrees that it will (i) furnish to the Stockholders and
to the underwriters of the Registrable Securities, if any, such reasonable
number of copies of the Registration Statement, preliminary prospectus and
prospectus supplement, final prospectus and
26
<PAGE>
prospectus supplement and such other documents as such Stockholders may
reasonably request in order to facilitate the public offering of the Registrable
Securities (ii) use its reasonable best efforts to register or qualify the
Registrable Securities covered by the Registration Statement under such state
securities or blue sky laws of such jurisdictions as the Stockholders may
reasonably request in writing within 20 days following the original filing of
the Registration Statement, except that BVI shall not for any purpose be
required to execute a general consent to service of process or to qualify to do
business as a foreign corporation in any jurisdiction wherein it is not so
qualified, (iii) notify the Stockholders, promptly after it shall receive notice
thereof, of the time when the Registration Statement has become effective or a
supplement to any prospectus forming a part of the Registration Statement has
been filed, (iv) notify the Stockholders promptly of any request by the SEC for
the amending or supplementing of the Registration Statement or prospectus or
prospectus supplement or for additional information, (v) prepare and file with
the SEC, promptly upon the request of any Stockholder, any amendments or
supplements to the Registration Statement or prospectus or prospectus supplement
which, in the opinion of counsel for the Stockholders (and concurred in by
counsel for BVI), is required under the 1933 Act or the rules and regulations
thereunder in connection with the distribution of the Registrable Securities by
such Stockholder, (vi) prepare and promptly file with the SEC and promptly
notify the Stockholders of the filing of such amendment or supplement to the
Registration Statement or prospectus or prospectus supplement as may be
necessary to correct any statements or omissions if, at the time when a
prospectus relating to such securities is required to be delivered under the
1993 Act, any event shall have occurred as the result of which any such
prospectus or any other prospectus or prospectus supplement as then in effect
would include an untrue statement of a material fact or omit to state any
material fact necessary to make the statements therein, in the light of the
circumstances in which they were made, not misleading, and (vii) advise the
Stockholders, promptly after BVI shall receive notice or obtain knowledge
thereof, of the issuance of any stop order by the SEC suspending the
effectiveness of the Registration Statement or the initiation or threatening of
any proceeding for that purpose and promptly use its reasonable best efforts to
prevent the issuance of any stop order or to obtain its withdrawal if such stop
order should be issued. Each Stockholder hereby agrees to cooperate with all
reasonable requests by BVI necessary to effectuate the preparation and filing of
the Registration Statement and agrees to provide the Company with all
information required in connection therewith in a timely manner and to comply
with the procedures specified in Section 7.6(b) below.
(b) Prior to any sales of Registrable Securities under the Registration
Statement by a Stockholder, the Stockholder contemplating the sales will provide
BVI with written notice of such intention, addressed to BVI's Chief Financial
Officer (a "Sale Notice"). BVI will notify such Stockholder within two (2)
business days following receipt of the Sale Notice as to whether sales by the
Stockholder may be made or will be limited as provided below. Upon notice from
BVI permitting sales by the Stockholder, for a period beginning on the date of
receipt by the Stockholder of such notice and ending 45 days thereafter (the
"Window Period"), the Stockholder may offer and sell Registrable Securities from
time to time pursuant to the Registration Statement. Anything in this Agreement
to the contrary notwithstanding, the ability of a Stockholder to sell
Registrable Securities pursuant to the Registration Statement and this Agreement
shall be suspended in the event that, upon receiving a Sale Notice or during any
Window Period, BVI's Chief Financial Officer certifies to the Stockholders that,
in the good
27
<PAGE>
faith judgment of such officer (upon consultation to the extent practicable with
the Board of Directors of BVI to the extent practicable), (A) the sale would
interfere in any material respect with any financing, acquisition, corporate
reorganization or other similar material transaction under consideration by BVI,
or (B) there is some other material development relating to the condition
(financial or otherwise) of BVI that has not been generally publicly disclosed
and as to which BVI deems advisable upon the advice of counsel at the time of
the Sale Notice not to publicly disclose; provided, however, that, upon any such
event specified in (A) or (B) above, BVI may not suspend sales by Stockholders
under the Registration Statement for a period of more than forty-five (45) days
from the date of such certification by BVI's Chief Financial Officer. If, upon
receipt of the Sale Notice, BVI has reasonably determined that it is necessary
to file and cause to be declared effective a post-effective amendment to the
Registration Statement or file a new or amended prospectus supplement or to
otherwise cause disclosure to be made under the 1934 Act and incorporated by
reference into the Registration Statement, and BVI determines not to rely on the
proviso set forth in the preceding sentence in order to delay the making of such
disclosure, BVI will take such action within seven (7) business days following
receipt of the applicable Sale Notice.
(c) If at any time following the date of this Agreement, BVI shall be
ineligible to register its securities on Form S-3 (other than by reason of gross
negligence or willful violation of BVI's covenant in Section 12.3(b) and 12.3(d)
hereof) then (i) BVI shall not be obligated to effect any registration of the
Registrable Securities under Section 7.6(a) until such time as BVI becomes
eligible to use Form S-3 (provided, however, that if at the time such
eligibility is restored all of the Registrable Securities held by a Stockholder
are then eligible for sale during any given three (3) month period under Rule
144 under the Securities Act, BVI will have no further registration obligation
under Section 7.6(a) with respect to such Stockholder's Registrable Securities);
and (ii) if the Registration Statement has become effective under the 1933 Act,
BVI may file an amendment to the Registration Statement deregistering any
Registrable Securities remaining unsold at the time that BVI became ineligible
to use Form S-3. In the event that BVI becomes ineligible to use Form S-3
through its gross negligence or willful misconduct and such ineligibility
remains uncured for a period of 10 days, BVI's obligation to register the
Registrable Securities will be deemed to extend to registration on Form S-1, S-2
or other applicable forms promulgated by the SEC. BVI will provide prompt notice
to the Stockholders of any ineligibility to use Form S-3 and of any
deregistration of the Registrable Securities under this Section.
(d) In connection with the registration of the Registrable Securities,
BVI shall bear the following fees, costs and expenses: all registration, filing
NASD and Nasdaq National Market or exchange listing fees, printing expenses,
fees and disbursements of counsel and accountants for BVI, all internal BVI
expenses and all legal fees and disbursements and other expenses of complying
with state securities or blue sky laws of any jurisdictions in which the
Registrable Securities are to be registered or qualified. Fees and disbursements
of counsel and accountants for the Stockholders, underwriting discounts and
commissions and transfer taxes relating to the Registrable Securities included
in the offering, and any other expenses incurred by the Stockholders not
expressly included above, shall be borne by the Stockholders.
(e) With respect to such registration:
28
<PAGE>
(i) Subject to compliance by a holder of Registrable Securities
with Section 7.6(b), BVI will indemnify and hold harmless each
holder of Registrable Securities which are included in the
Registration Statement, and any underwriter (as defined in the 1933
Act) for such holder and each person, if any, who controls such
holder or such underwriter within the meaning of the 1933 Act, from
and against, and will reimburse such holder and each such
underwriter and controlling person with respect to, any and all
loss, damage, liability, cost and expense to which such holder or
any such underwriter or controlling person may become subject under
the 1933 Act or otherwise, insofar as such losses, damages,
liabilities, costs or expenses are caused by any untrue statement
or alleged untrue statement of any material fact contained in the
Registration Statement, any prospectus or prospectus supplement
contained therein or any amendment or supplement thereto, or arise
out of or are based upon the omission or alleged omission to state
therein a material fact required to be stated therein or necessary
to make the statements therein, in light of the circumstances in
which they were made, not misleading; provided, however, that BVI
will not be liable in any such case to the extent that any such
loss, damage, liability, cost or expense arises out of or is based
upon an untrue statement or alleged untrue statement or omission or
alleged omission so made in conformity with information furnished
by such holder, such underwriter or such controlling person in
writing specifically for use in the preparation thereof.
(ii) Each holder of Registrable Securities which are included in
the Registration Statement will indemnify and hold harmless BVI,
its directors and officers, and any controlling person thereof and
any underwriter from and against, and will reimburse BVI, its
directors and officers, and any such controlling person and any
underwriter with respect to, any and all loss, damage, liability,
cost or expense to which BVI or any controlling person and any
underwriter may become subject under the 1933 Act or otherwise,
insofar as such losses, damages, liabilities, costs or expenses are
caused by any untrue or alleged untrue statement of any material
fact contained in the Registration Statement, any prospectus or
prospectus supplement contained therein or any amendment or
supplement thereto, or arise out of or are based upon the omission
or the alleged omission to state therein a material fact required
to be stated therein or necessary to make the statements therein,
in light of the circumstances in which they were made, not
misleading, in each case to the extent, but only to the extent,
that such untrue statement or alleged untrue statement or omission
or alleged omission was so made in reliance upon and in strict
conformity with written information furnished by such holder
specifically for use in the preparation thereof.
(f) For the purposes of this Section 7.6, the term "Registrable
Securities" shall mean (i) the Restricted Shares, and (ii) any BVI Common Stock
issued or issuable with respect to such Restricted Shares by way of a stock
dividend or stock split or in connection with a combination of shares,
recapitalization, merger, consolidation or other reorganization or a sale of
substantially all of BVI's assets.
29
<PAGE>
7.7. RESIGNATIONS. The individuals set forth on Schedule 7.7 shall deliver their
resignations as officers and directors of the Company effective as of the
Closing Date.
7.8. RELEASE OF GUARANTIES. Concurrently with the execution of this Agreement,
George N. Nelson, Jr. and James F. Pfau shall be released from the Guaranties
relating to indebtedness of the Company owed to Norwest Bank Minnesota, N.A. and
its Affiliates.
7.9. INSURANCE. In the event BVI or Newco determines to cancel or reduce any of
the insurance coverages described on Schedule 7.9, the effect of which may
result in an increase in the Stockholders' indemnification obligations
hereunder, each of BVI and Newco shall use its reasonable best efforts to
provide the Stockholders with notice of such action at least 30 days prior to
the date such cancellation or reduction will take effect and will cooperate (at
no cost to BVI or Newco) with any Stockholder who desires to purchase
continuation or "tail" coverage for such canceled or reduced insurance policy.
7.10. LIFE INSURANCE POLICIES. Each of George Nelson, Jr., James Pfau, John
Wright and John Reed shall have the option, for a period of five (5) business
days after the Closing Date, to assume the key man life insurance policy or
policies currently held by the Company on such person's life and the Surviving
Corporation will permit any such transfer and will take all actions necessary to
release and terminate the interest of Norwest Bank Minnesota, N.A. in such
policies and will take all other actions (at no cost to the Surviving
Corporation) reasonably requested to facilitate such purchase.
ARTICLE VIII
INDEMNIFICATION
The Stockholders, BVI and Newco each make the following covenants:
8.1. GENERAL INDEMNIFICATION BY THE STOCKHOLDERS.
(a) Subject to Section 8.4, each of the Stockholders covenants and
agrees that such Stockholder will severally indemnify, defend, protect and hold
harmless BVI, Newco and the Surviving Corporation, and their respective
officers, directors, employees, stockholders, agents, representatives and
Affiliates, from and against all Losses incurred by any of such indemnified
persons as a result of or arising from (i) any breach of the representations and
warranties of such Stockholder set forth in Sections 5.31, 5.32, 12.1 and 12.2,
(ii) any breach or nonfulfillment of any covenant or agreement on the part of
such Stockholder under this Agreement, and (iii) all transfer taxes arising from
the transactions contemplated by this Agreement (for each Stockholder, the items
listed in clauses (i), (ii) and (iii), referred to collectively as such
Stockholder's "Individual Stockholder Indemnification Obligations").
(b) Subject to Section 8.4, the Stockholders covenant and agree that
they will jointly and severally indemnify, defend, protect and hold harmless
BVI, Newco and the Surviving Corporation, and their respective officers,
directors, employees, stockholders, agents, representatives and Affiliates, from
and against all Losses incurred by any of such indemnified
30
<PAGE>
persons as a result of or arising from any breach of the representations and
warranties of the Stockholders set forth in Article V except those set forth in
Sections 5.31 and 5.32.
An escrow fund to be funded in cash in the amount of $100,000 shall be
established at Closing (the "Escrow") pursuant to the terms of the Escrow
Agreement attached to this Agreement as Schedule 8.1., such fund to be comprised
of $85,000 contributed by Ronald Breckner and $15,000 contributed by James Pfau
(such amounts to be deducted from the Merger Consideration due each of them at
Closing).
8.2. INDEMNIFICATION BY BVI. Subject to Section 8.4, BVI , Newco and the
Surviving Corporation covenant and agree that they will jointly and severally
indemnify, defend, protect and hold harmless the Stockholders and their
respective agents, representatives, Affiliates, beneficiaries and heirs and
employees from and against all Losses incurred by any of such indemnified
persons as a result of or arising from (a) any breach of the representations and
warranties of BVI or Newco set forth herein, (b) any breach or nonfulfillment of
any covenant or agreement on the part of BVI or Newco under this Agreement, and
(c) any facts or circumstances first arising, or actions or inactions of the
Surviving Corporation or BVI occurring solely after the Closing which result in
liability to the Stockholders as a result of their former capacities as
officers, directors or shareholders of the Company.
8.3. THIRD PERSON CLAIMS. Promptly after any party hereto (hereinafter the
"Indemnified Party") has received notice of or has knowledge of any claim by a
person not a party to this Agreement ("Third Person"), of the commencement of
any action or proceeding by a Third Person, which the Indemnified Party believes
in good faith is an indemnifiable claim under this Agreement, the Indemnified
Party shall give to the party obligated to provide indemnification pursuant to
Section 7.6, 8.1, or 8.2 hereof (hereinafter the "Indemnifying Party") written
notice of such claim or the commencement of such action or proceeding; provided,
that the failure of the Indemnified Party promptly to notify the Indemnifying
Party of any such matter shall not release the Indemnifying Party, in whole or
in part, from its obligations under Section 7.6 or this Article VIII except to
the extent the Indemnified Party's failure to so notify in breach of this
paragraph materially prejudices the Indemnifying Party's ability to defend
against such third party claim or litigation. Such notice shall state the nature
and the basis of such claim. The Indemnifying Party shall have the right to
defend and settle, at its own expense and by its own counsel, any such matter so
long as the Indemnifying Party pursues the same diligently and in good faith. If
the Indemnifying Party undertakes to defend or settle, it shall promptly notify
the Indemnified Party of its intention to do so, and the Indemnified Party shall
cooperate with the Indemnifying Party and its counsel in all commercially
reasonable respects in the defense thereof and in any settlement thereof. Such
cooperation shall include, but shall not be limited to, furnishing the
Indemnifying Party with any books, records and other information reasonably
requested by the Indemnifying Party and in the Indemnified Party's possession or
control. After the Indemnifying Party has notified the Indemnified Party of its
intention to undertake to defend or settle any such asserted liability, and for
so long as the Indemnifying Party diligently pursues such defense, the
Indemnifying Party shall not be liable for any additional legal expenses
incurred by the Indemnified Party in connection with any defense or settlement
of such asserted liability; provided, however, that the Indemnified Party shall
be entitled, at its expense, to participate in the defense of such asserted
liability and the negotiations of the settlement thereof
31
<PAGE>
and provided, further, if the defendants in any action include both the
Indemnified Party and the Indemnifying Party and the Indemnified Party shall
have reasonably concluded that there may be legal defenses available to it
and/or other indemnified parties which are different from or additional to those
available to the Indemnifying Party, or if there is a conflict of interest which
would prevent counsel for the Indemnifying Party from also representing the
Indemnified Party, the Indemnified Party or parties shall have the right to
select separate counsel to participate in the defense of such action on behalf
of such Indemnified Party or Parties, at the expense of the Indemnifying Party.
The Indemnifying Party shall not settle any such Third Person claim without the
consent of the Indemnified Party, unless the settlement thereof imposes no
liability or obligation on, and includes a complete release from liability of,
the Indemnified Party. If the Indemnifying Party desires to accept a final and
complete settlement of any such Third Person claim and the Indemnified Party
refuses to consent to such settlement, then the Indemnifying Party's liability
under this Section with respect to such Third Person claim shall be limited to
the amount so offered in settlement by said Third Person; provided, however,
that notwithstanding the foregoing, the Indemnified Party shall be entitled to
refuse to consent to any such proposed settlement and the Indemnifying Party's
liability hereunder shall not be limited by the amount of the proposed
settlement if such settlement does not provide for the complete release of the
Indemnified Party. If, upon receiving notice, the Indemnifying Party does not
undertake to defend such matter within thirty (30) days to which the Indemnified
Party is entitled to indemnification hereunder, or fails diligently to pursue
such defense, the Indemnified Party may undertake such defense through counsel
of its choice, at the cost and expense of the Indemnifying Party, and the
Indemnified Party may settle such matter, in its sole and absolute discretion,
and the Indemnifying Party shall reimburse the Indemnified Party to the extent
the amount paid in such settlement and any other liabilities or expenses
incurred by the Indemnified Party in connection therewith are indemnifiable
Losses under this Agreement. Except as provided in writing to such effect signed
by such person, no action or inaction of an Indemnifying Party under this
Section 8.3 shall be deemed a waiver of such person's right to contest any claim
for indemnification under this Agreement.
8.4. INDEMNIFICATION DEDUCTIBLE. In no event shall any Stockholder be liable
under Section 8.1(b) hereof unless the Losses therefrom exceed $100,000 and then
only to the extent the Losses exceed $100,000. The parties hereto acknowledge
and agree that each of Willard Sykes and Catherine Sykes shall only have
indemnification obligations pursuant to Section 8.1(a) with respect to
Individual Stockholder Indemnification Obligations and will not have
indemnification obligations pursuant to Section 8.1(b) as a result of any
breaches of any representation and warranties contained in Article V hereof
other than those made by such Stockholders in Section 5.31. In no event shall
the liability of any Stockholder for Losses resulting from such Stockholder's
Individual Stockholder Indemnification Obligations (other than Losses resulting
from a breach of the terms and conditions of Sections 9.1 or 10.1 of this
Agreement), exceed the following amounts:
32
<PAGE>
G. Nelson, Jr. - $1,127,500
R. Breckner - $1,100,000
J. Pfau - $357,500
W. Sykes $82,500
C. Sykes $82,5000
In no event shall the liability of any Stockholder for all Losses pursuant to
Section 8.1 hereof, (other than Losses resulting from a breach of the terms and
conditions of Sections 9.1 or 10.1 of this Agreement) including and together
with any liability for Losses for which such Stockholder is responsible pursuant
to the preceding sentence, exceed the following amounts:
G. Nelson, Jr. - $1,174,250
R. Breckner - $1,146,750
J. Pfau - $429,000.
In no event shall the liability of any Stockholder for Losses resulting from
such Stockholder's breach of the terms and conditions of Sections 9.1 and 10.1
of this Agreement exceed the following amounts:
G. Nelson, Jr. - $2,750,000
R. Breckner - $2,750,000
J. Pfau - $2,750,000
W. Sykes $2,750,000
C. Sykes $2,750,000
In no event shall BVI, Newco and the Surviving Corporation be liable under
Section 8.2 hereof, unless the Losses therefrom exceed $100,000 and then only to
the extent the Losses exceed $100,000. In no event shall the liability of BVI,
Newco and the Surviving Corporation for Losses pursuant to Section 8.2 hereof
exceed $2,750,000 in the aggregate.
8.5. SUBROGATION. At the Stockholders' joint election, the Stockholders shall be
subrogated to any claims or rights of BVI or Newco as against any other persons
with respect to any Losses paid by any Stockholder under this Article VIII;
provided that the Stockholders vigorously pursue such claim against such other
persons and pay to BVI or Newco, as appropriate, all amounts received from such
other persons until such time as BVI's or Newco's Losses have been reduced to
zero and provided further, that the obligations of the Stockholders to BVI,
Newco and the Surviving Corporation in accordance with Section 8.1 of this
Agreement shall not be contingent upon or delayed by the Stockholders' pursuit
of any subrogated claims in accordance with this Section 8.5. BVI and Newco
shall cooperate with the Stockholders, to the extent reasonable under the
circumstances, at the sole expense of Stockholders, in connection with the
assertion by the Stockholders of any such claim against any such other persons;
provided that BVI and Newco shall not be required to institute litigation or
file any claim in a proceeding.
8.6. SURVIVAL OF REPRESENTATIONS AND WARRANTIES. The representations and
warranties set forth in ARTICLE V and ARTICLE VI shall survive the Closing for a
period of eighteen months from the Closing Date (the "Expiration Date"), except
that the representations and warranties set
33
<PAGE>
forth in SECTIONS 5.3, 5.16, 5.18, 5.31(B) AND 5.32(A) hereof shall survive the
transaction contemplated by this Agreement and not terminate and the Expiration
Date shall not be applicable to said representations. Notwithstanding anything
in this Article VIII to the contrary, an Indemnifying Party's indemnification
obligations under Article VIII shall not terminate as of the Expiration Date
with respect to any claims for indemnification to which the Expiration Date
would otherwise be applicable which are asserted in writing prior to the
Expiration Date and have not been finally resolved prior to the Expiration Date.
8.7. ADDITIONAL NOTICE; COOPERATION. In addition to any notice which BVI, the
Surviving Corporation or Newco may give to the Stockholders pursuant to this
Article VIII, BVI, the Surviving Corporation and Newco agree that they shall
give written notice to the Stockholders promptly upon the receipt by BVI, the
Surviving Corporation or Newco of knowledge of a state of facts which, if not
corrected, would in BVI's, the Surviving Corporation's or Newco's judgment be
reasonably likely to become the subject of a claim for indemnification
hereunder; provided, that the failure of BVI, the Surviving Corporation or Newco
promptly to notify the Stockholders of any such matter shall not release the
Stockholders, in whole or in part, from their obligations under this Article
VIII.
8.8. EXCLUSIVE REMEDY. The indemnification provisions of this Article VIII shall
be the sole and exclusive remedy of BVI, Surviving Corporation, Newco and the
Stockholders relative to the matters set forth herein and are in lieu of any
other statutory, equitable, common law or other remedy BVI, Surviving
Corporation, Newco or the Stockholders may have relative to the matters set
forth therein, other than claims for specific performance or other equitable
relief pursuant to Sections 9.2 and 10.2 and other than claims based in fraud
and other than claims made pursuant to Section 7.6.
ARTICLE IX
NONCOMPETITION COVENANTS
9.1 PROHIBITED ACTIVITIES.
(a) For the additional consideration of $950,000 to be allocated among
the Stockholders in accordance with Schedule 9.1, each Stockholder hereby agrees
that such Stockholder will not for ten years following the Closing Date directly
or indirectly, for himself or on behalf of or in conjunction with any other
person, company, partnership, corporation or business of whatever nature:
(i) engage, as an officer, director, shareholder, owner, partner,
joint venturer, or in a managerial or advisory capacity,
whether as an employee, independent contractor, consultant or
advisor, or as a sales representative, in the Business any
where in the world (such areas being herein referred to as
the "Territory");
(ii) call upon any person, who is, at that time, an employee or
consultant of BVI or the Surviving Corporation or any of
their respective subsidiaries,
34
<PAGE>
for the purpose or with the intent or effect of enticing such
employee or consultant away from or out of the employ or
contract with BVI or the Surviving Corporation or any of
their respective subsidiaries; or
(iii) call upon any person or entity which is, at that time, or
which has been, within one year prior to that time, a
customer of the Company, BVI or the Surviving Corporation or
any of the subsidiaries of such parties within the Territory
for the purpose of soliciting or selling services or products
in the Business within the Territory.
(b) Notwithstanding the above, Section 9.1(a) shall not be deemed to
prohibit any Stockholder from acquiring, as a passive investor with no
involvement in the operations of the business, not more than 4.99 percent of the
capital stock of an entity engaged in the Business.
9.2. EQUITABLE RELIEF. Because of the difficulty of measuring economic losses to
BVI and the Surviving Corporation as a result of a breach of the foregoing
covenant, because a breach of such covenant would diminish the value of the
Company being sold pursuant to this Agreement, and because of the immediate and
irreparable damage that could be caused to BVI and the Surviving Corporation for
which they would have no other adequate remedy, each Stockholder agrees that the
foregoing covenant may be enforced against such individual by injunctions,
restraining orders and other equitable actions.
9.3. REASONABLE RESTRAINT. It is agreed by the parties hereto that the foregoing
covenants in this ARTICLE IX are necessary in terms of time, activity and
territory to protect BVI's and the Surviving Corporation's interest in the
shares being acquired pursuant to the terms of this Agreement and impose a
reasonable restraint on each Stockholder in light of the activities and
businesses of the Company on the date of the execution of this Agreement and the
current plans of the Company.
9.4. SEVERABILITY; REFORMATION. The covenants in this ARTICLE IX are severable
and separate, and the unenforceability of any specific covenant shall not affect
the continuing validity and enforceability of any other covenant. In the event
any court of competent jurisdiction shall determine that the scope, time or
territorial restrictions set forth in this ARTICLE IX are unreasonable and
therefore unenforceable, then it is the intention of the parties that such
restrictions be enforced to the fullest extent which the court deems reasonable
and this Agreement shall thereby be reformed.
9.5. MATERIAL AND INDEPENDENT COVENANT. Each Stockholder acknowledges that his
or her agreements and the covenants set forth in this ARTICLE IX are material
conditions to BVI's and Newco's agreements to execute and deliver this Agreement
and to consummate the transactions contemplated hereby and that BVI and Newco
would not have entered into this Agreement without such covenants. All of the
covenants in this ARTICLE IX shall be construed as an agreement independent of
any other provision in this Agreement.
35
<PAGE>
ARTICLE X
NONDISCLOSURE OF CONFIDENTIAL INFORMATION
10.1 GENERAL. Each Stockholder recognizes and acknowledges that he or she has in
the past or currently has access to certain confidential information relating to
the businesses of the Company, such as lists of customers, operational policies,
and pricing and cost policies that are, and following the Closing will be,
valuable, special and unique assets of the Surviving Corporation. Each
Stockholder agrees that he or she will not use or disclose such confidential
information to any person, firm, corporation, association or other entity for
any purpose whatsoever, except as is required in the course of performing his or
her duties, if any, to the Surviving Corporation and/or BVI, unless (a) such
information becomes known to the public generally through no fault of such
Stockholder, or (b) disclosure is required by Law, provided that prior to
disclosing any information pursuant to this clause (b) such Stockholder shall,
if possible, give prior written notice thereof to BVI and the Surviving
Corporation and provide BVI with the opportunity to contest such disclosure. In
the event of a breach or threatened breach by any Stockholder of the provisions
of this Section, BVI shall be entitled to an injunction restraining such
Stockholder from disclosing, in whole or in part, such confidential information.
Nothing herein shall be construed as prohibiting BVI from pursuing any other
available remedy for such breach or threatened breach, including, without
limitation, the recovery of damages.
10.2. EQUITABLE RELIEF. Because of the difficulty of measuring economic losses
as a result of the breach of the foregoing covenants, because a breach of such
covenant would diminish the value of the Company being sold pursuant to this
Agreement, and because of the immediate and irreparable damage that would be
caused for which the Surviving Corporation and/or BVI would have no other
adequate remedy, each Stockholder agrees that the foregoing covenants may be
enforced against him or her by injunctions, restraining orders and other
equitable actions.
ARTICLE XI
INTENDED TAX TREATMENT
11.1 TAX-FREE REORGANIZATION. BVI and the Stockholders are entering into this
Agreement with the intention that the Merger qualify as a tax-free
reorganization within the meaning of Section 368(a)(2)(D) of the Code for
federal income tax purposes, except to the extent of any "boot" received, and
neither BVI nor the Stockholders will take any actions that disqualify the
Merger for such treatment. Notwithstanding the foregoing, the parties
acknowledge that none of them has filed a request for a private letter ruling
with the Internal Revenue Service that the Merger is a tax-free reorganization
within the meaning of Section 368(a) of the Code. In the event of a final
determination by the Internal Revenue Service that the Merger is not a tax-free
reorganization, BVI and the Surviving Corporation hereby agree that (i) they,
and not the Stockholders, shall be responsible for any taxes, interest and
penalties that would result from the taxation of the Company, and (ii) the
Stockholders, and not BVI or the Surviving Corporation, shall be responsible for
any taxes, interest and penalties resulting from their status as stockholders of
the Company or from their receipt of the Merger Consideration in the Merger.
36
<PAGE>
ARTICLE XII
FEDERAL SECURITIES ACT OF 1933 AND CONTRACTUAL RESTRICTIONS
ON BVI COMMON STOCK
12.1 COMPLIANCE WITH LAW. Each of the Stockholders acknowledges that the shares
of BVI Common Stock issued at the Closing in accordance with the terms of this
Agreement (the "Restricted Shares") will not as of the Closing Date be
registered under the 1933 Act and therefore may not be resold without compliance
with the 1933 Act. The Restricted Shares are being or will be acquired by each
of the Stockholders solely for his or her own account and without a view to
distribution within the meaning of the 1933 Act. Each of the Stockholders
covenants, warrants and represents that none of the Restricted Shares will be,
directly or indirectly, offered, sold, assigned, pledged, hypothecated,
transferred or otherwise disposed of except after full compliance with all of
the applicable provisions of the 1933 Act and the rules and regulations
thereunder. Certificates representing the Restricted Shares shall bear a legend
in substantially the following language:
THE SHARES REPRESENTED BY THIS CERTIFICATE WERE NOT ISSUED IN A
TRANSACTION REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED
("1933 ACT"), OR ANY APPLICABLE STATE SECURITIES LAWS. THE SHARES
REPRESENTED HEREBY HAVE BEEN ACQUIRED WITHOUT A VIEW TO DISTRIBUTION
WITHIN THE MEANING OF THE 1933 ACT AND MAY NOT BE SOLD OR TRANSFERRED
UNLESS SUCH SALE OR TRANSFER IS COVERED BY AN EFFECTIVE REGISTRATION
STATEMENT UNDER THE 1933 ACT AND APPLICABLE STATE SECURITIES LAWS OR,
IN THE OPINION OF COUNSEL TO THE ISSUER, IS EXEMPT FROM THE
REGISTRATION REQUIREMENTS OF THE 1933 ACT AND SUCH LAWS.
12.2. ECONOMIC RISK; SOPHISTICATION. Each Stockholder is able to bear the
economic risk of an investment in the Restricted Shares and can afford to
sustain a total loss of such investment. Each Stockholder represents to BVI and
Newco that such Stockholder is an "accredited investor," as that term is defined
in Regulation D under the 1933 Act for the reasons specified on such
Stockholder's Certification, the form of which is attached hereto as Schedule
12.2. Each Stockholder or her or his representatives have had an adequate
opportunity to ask questions and receive answers from the officers of BVI and
Newco concerning, among other matters, BVI, its management, its plans for the
operation of its business and potential additional acquisitions.
12.3. RULE 144 REPORTING. With a view to making available the benefits of
certain rules and regulations of the SEC that may permit the resale of BVI
Common Stock to the public without registration and to maintain eligibility for
the use of Form S-3, for a period of two years after the Closing, BVI agrees to
use its commercially reasonable efforts to:
(a) make and keep current public information (as contemplated by Rule
144) regarding BVI available;
(b) file with the SEC in a timely manner all reports and other
documents required of BVI under the 1933 Act and the 1934 Act;
37
<PAGE>
(c) furnish to each Stockholder upon written request a written
statement by BVI as to its compliance with the reporting requirements of Rule
144, the 1933 Act and the 1934 Act, a copy of the most recent annual or
quarterly report of BVI, and such other reports and documents so filed as such
Stockholder may reasonably request in availing himself of any rule or regulation
of the SEC allowing such Stockholder to resell any such shares without
registration; and
(d) not fail to pay any dividend or sinking fund installment on
preferred stock or default on either (a) any installment on indebtedness for
borrowed money or (b) on any rental on long term leases, which defaults in the
aggregate are material to the consolidated financial position of BVI.
ARTICLE XIII
MISCELLANEOUS
13.1 SUCCESSORS AND ASSIGNS. This Agreement and the rights of the parties
hereunder may not be assigned (except by operation of Law) and shall be binding
upon and shall inure to the benefit of the parties hereto, the successors of
BVI, Newco, the Surviving Corporation and the Company, and the heirs and legal
representatives of the Stockholders.
13.2. ENTIRE AGREEMENT. Except as referenced on Schedule 13.2, this Agreement
(including the Schedules, exhibits and annexes attached hereto) and the
documents delivered pursuant hereto constitute the entire agreement and
understanding among the Stockholders, the Company, Newco and BVI and supersede
any prior agreement and understanding relating to the subject matter of this
Agreement. Except for the representations and warranties of BVI, Newco, the
Company and the Stockholders, which are contained in this Agreement, there are
no other representations and warranties by or on behalf of BVI, Newco, the
Company or the Stockholders which are being relied upon by the parties hereto.
Any provision of this Agreement may be modified, amended or waived only by a
written instrument duly executed by the Stockholders, the Company, Newco and BVI
in the case of an amendment or modification, or by the party against whom the
waiver is to be effective, in the case of a waiver.
13.3. COUNTERPARTS. This Agreement may be executed simultaneously in two or more
counterparts, each of which shall be deemed an original and all of which
together shall constitute but one and the same instrument.
13.4. BROKERS AND AGENTS. Except as set forth on Schedule 13.4, each party
hereto represents and warrants that it employed no broker or agent (collectively
"Broker") in connection with the transactions contemplated by this Agreement.
Each party agrees to indemnify each other party against all loss, cost, damages
or expense arising out of claims for fees or commissions of brokers employed or
alleged to have been employed by such Indemnifying Party. Any fee or commission
payable to the Brokers or Agents described in Schedule 13.4 shall be paid by the
Stockholders.
13.5. NOTICES. All notices and communications required or permitted hereunder
shall be in writing and may be given by depositing the same in the United States
mail, addressed to the
38
<PAGE>
party to be notified, postage prepaid and registered or certified with return
receipt requested, by fax or telecopy or by delivering the same in person to an
officer or agent of such party, or by a national courier service as follows:
(a) If to BVI, Newco or the Surviving Corporation, addressed to them
at:
Bio-Vascular, Inc.
2525 University Avenue
St. Paul, MN 55114-1024
Attn: M. Karen Gilles
Fax number (651) 642-9018
With a copy (which shall not constitute notice) to:
Winthrop & Weinstine, P.A.
Edward J. Drenttel, Esq.
3000 Dain Rauscher Plaza
60 South Sixth Street
Minneapolis, Minnesota 55402
Fax number (612) 347-0600
(b) If to any Stockholder, respectively addressed as follows:
George Nelson, Jr.
1777 Knox Avenue South
Minneapolis, Minnesota 55403
Ronald Breckner
c/o Data Sales Co.
3450 West Burnsville Parkway
Burnsville, Minnesota 55337
James Pfau
1788 Fremont
Minneapolis, Minnesota 55403
Willard Sykes
13090 182nd Street North
Marine on the St. Croix, Minnesota 55047
Catherine Sykes
13090 182nd Street North
Marine on the St. Croix, Minnesota 55047
39
<PAGE>
With a copy (which shall not constitute notice) to:
Sonia A. Shewchuk, Esq.
Faegre & Benson, LLP
90 South Seventh Street
Minneapolis, Minnesota 55402
or such other address as any party hereto shall specify pursuant to this Section
13.5 from time to time.
All such notices or other communications shall be deemed to have been received
as follows: when delivered by hand, if personally delivered; three (3) business
days after being deposited in the U.S. mail, postage pre-paid, if delivered by
mail; when receipt is electronically acknowledged, if faxed or telecopied; and
the next day after being delivered to an overnight delivery service if sent by
overnight delivery service.
13.6. EXERCISE OF RIGHTS AND REMEDIES. Except as otherwise provided herein, no
delay of or omission in the exercise of any right, power or remedy accruing to
any party as a result of any breach or default by any other party under this
Agreement shall impair any such right, power or remedy, nor shall it be
construed as a waiver of or acquiescence in any such breach or default, or of
any similar breach or default occurring later; nor shall any waiver of any
single breach or default be deemed a waiver of any other breach or default
occurring before or after that waiver.
13.7. REFORMATION AND SEVERABILITY. In case any provision of this Agreement
shall be invalid, illegal or unenforceable, it shall, to the extent possible, be
modified in such manner as to be valid, legal and enforceable, but so as to most
nearly retain the intent of the parties, and if such modification is not
possible, such provision shall be severed from this Agreement, and in either
case, the validity, legality and enforceability of the remaining provisions of
this Agreement shall not in any way be affected or impaired thereby.
13.8. THIRD PARTY BENEFICIARIES. Nothing provided in this Agreement is intended
to provide any rights or benefits to third parties.
13.9. GOVERNING LAW; JURISDICTION; SERVICE OF PROCESS . This Agreement shall be
governed by the laws of the State of Minnesota, its rules of conflict of laws
notwithstanding.
THIS SPACE INTENTIONALLY LEFT BLANK
40
<PAGE>
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
date first written above.
BIO-VASCULAR, INC.
By:
-------------------------------------
Its:
------------------------------------
JER-NEEN ACQUISITION, INC.
By:
------------------------------------
Its:
-----------------------------------
JER-NEEN MANUFACTURING CO., INC.
By:
------------------------------------
Its:
-----------------------------------
---------------------------------------
George Nelson, Jr., Individually
---------------------------------------
Ronald Breckner, Individually
---------------------------------------
James Pfau, Individually
---------------------------------------
Willard Sykes, Individually
---------------------------------------
Catherine Sykes, Individually
SIGNATURE PAGE FOR ACQUISITION AGREEMENT AND PLAN OF
REORGANIZATION, DATED JULY 31, 1998 MPL1: 248452-9
41
<PAGE>
EXHIBIT 10.1
EMPLOYMENT AGREEMENT
THIS AGREEMENT, made and entered into this 31st day of July, 1998 by and between
Jer-Neen Manufacturing Co., Inc. (the "Employer") and James F. Pfau (the
"Executive").
W I T N E S S E T H :
WHEREAS, the Employer is a wholly owned subsidiary of Bio-Vascular, Inc.
("BVI");
WHEREAS, BVI formed the Employer with the name Jer-Neen Acquisition, Inc. in
order to facilitate the merger of Jer-Neen Manufacturing Co., Inc. ("Jer-Neen")
with and into the Employer (the "Merger) in accordance with the terms of that
certain Acquisition Agreement and Plan of Reorganization by and among BVI, the
Employer, Jer-Neen, George Nelson, Jr., Ronald Breckner, James Pfau, Willard
Sykes and Catherine Sykes (the "Merger Agreement");
WHEREAS, the name of the Employer was changed to Jer-Neen Manufacturing Co.,
Inc. in accordance with the terms of the Merger Agreement;
WHEREAS, the Executive was previously employed by Jer-Neen and the Employer
desires to secure the services of the Executive for and on behalf of the
Employer on the terms and subject to the conditions set forth herein; and
WHEREAS, each of the parties acknowledge that they are receiving good and
valuable consideration for entering into this Employment Agreement and Executive
acknowledges that this Employment Agreement, including the covenant not to
compete set forth hereinbelow, was negotiated between the parties hereto and
that Executive has received bargained for consideration in accordance with the
terms of the Merger Agreement including, without limitation, consideration for
his shares of Jer-Neen stock and other benefits resulting to Executive from the
terms and conditions of such employment, in exchange for entering into this
Employment Agreement.
NOW, THEREFORE, in consideration of the mutual covenants contained herein, the
sufficiency of which is hereby acknowledged, the parties hereto agree as
follows:
ARTICLE I.
EMPLOYMENT AND TERM
1.1 EMPLOYMENT. Upon the terms and subject to the conditions herein contained,
the Employer hereby employs the Executive as President, and the Executive hereby
accepts such employment.
1.2 TERM. Except as otherwise provided in this Agreement, the original term of
this Agreement shall be three (3) years, commencing on the 31st day of July,
1998 (the "Commencement Date") and ending on the 30th day of July, 2001 (the
"Original Term")
<PAGE>
whereupon this Agreement shall terminate and, except as otherwise provided
herein, neither the Employer nor the Executive shall have any further rights,
duties, privileges or obligations hereunder.
ARTICLE II.
COMPENSATION
2.1 BASE SALARY. In exchange for the provision of services, the Executive shall
receive a salary in the amount of One Hundred Thirty-two Thousand and 00/100
Dollars ($132,000.00) (the "Base Salary") payable in accordance with the
Employer's customary wage payment policies and practices for all Executives. The
Base Salary will be reviewed annually and may be adjusted, as approved by the
Board based upon criteria normally relevant to salary adjustments including,
without limitation, the Executive's performance, on the anniversary of the
Commencement Date.
2.2 CASH INCENTIVE BONUS. As an incentive to performance, Executive will be
eligible to earn an annual bonus of up to twenty percent (20%) of the
Executive's Base Salary for each calendar year in accordance with the criteria
provided in Exhibit A to this Agreement. The criteria in Exhibit A may be
adjusted from time to time by the Board in its sole discretion but upon
consultation with the Executive. The Board shall provide such earned bonus
payment for each fiscal year by December 31 of the next fiscal year. The
Executive's eligibility for a cash incentive bonus in accordance with the terms
of this Section 2.2 shall commence with the Employer's fiscal year beginning on
November 1, 1998. Executive will also be eligible to earn an annual bonus for
the fiscal year ending October 31, 1998 in accordance with the terms and
conditions of Jer-Neen's annual bonus program, provided, that the determination
of the Executive's entitlement to such bonus shall be made by the Chief
Executive Officer of BVI.
2.3 BENEFITS. Executive shall be entitled to participate in any profit sharing
plan, life insurance, health insurance, dental insurance, disability insurance
or any other fringe benefit which the Employer may from time to time make
available to its Executives. Any additional fringe benefits to Executive shall
be determined and approved by the Board of Directors of Employer in amounts that
are commensurate with services rendered.
2.4 VACATION. The Executive will be entitled to earn fifteen (15) business days
of annual vacation proratably throughout the year beginning on the commencement
date. It is acknowledged that in computing the years of service to Employer for
purposes of the Employer's vacation policy, Executive has been given credit for
his previous four (4) years of service with Jer-Neen. Any increases in
Executive's paid annual vacation shall be in conformity with the currently
existing vacation policy of the Employer.
2.5 SEVERANCE PAYMENT AND BENEFITS UPON TERMINATION. In the event that
Executive's employment is terminated by the Employer for reasons other than (i)
cause as
-2-
<PAGE>
defined in Paragraph 4.1 of this Agreement, or (ii) a change in control as
defined in the Change in Control Agreement attached hereto as Exhibit B (the
"Change in Control Agreement"), the Executive shall receive:
(a) a cash severance payment equal to the difference between the
amount of Base Salary the Executive was actually paid between
the date of this Agreement and the date of the Executive's
termination of employment, and the total amount of Base Salary
that Executive was entitled to receive pursuant to the terms of
this Agreement if the Executive were employed for the full
amount of the Original Term (the "Termination Payment"). This
Termination Payment will be payable in equal payments during the
period between the date of the Executive's termination and the
expiration of the Original Term (the "Severance Term") in
accordance with the Employer's customary wage payment policies
and practices and shall be subject to federal and state tax
withholding and FICA.
(b) The Employer will also provide to the Executive, at the
Employer's expense, group medical and dental insurance during
the Severance Term in an amount equal to that portion of such
benefits that the Employer paid the Executive for such benefits
immediately preceding the date of the Executive's termination
(the "Employer Contribution Amount"), it being acknowledged and
agreed that such Employer Contribution Amount will be paid
directly to the Employer's insurer for any such benefits to be
paid during the first eighteen months following the date of
termination of Employment and, if necessary, directly to the
Executive thereafter.
(c) In addition to the group medical and dental paid to Executive
during the Severance Term, subject to the condition that the
Employer's disability insurance plan permits such participation
by the Executive, the Employer will provide to the Executive
during the Severance Term, at the Employer's expense, in an
amount equal to the Employer Contribution Amount, group
disability insurance. However, nothing herein obligates the
Employer to modify or amend in any manner whatsoever its
disability insurance plan to accommodate the Executive, although
the Employer may make such modifications or amendments, at its
sole discretion, if it is consistent with the Employer's
developing employment policies.
(d) In addition to the group medical, dental and disability benefits
paid to the Executive during the Severance Term, subject to the
condition that the applicable Employer's plans permit such
participation by the Executive, the Employer will provide to the
Executive, at the Employer's expense, in an amount equal to the
Employer Contribution Amount, group medical, dental, life and
disability insurance for the period between the expiration date
of the Severance Term and the later date of (i) the third
anniversary of the date of the termination of the Executive's
employment or (ii) the date the Executive has attained age 62.
-3-
<PAGE>
However, nothing herein obligates the Employer to modify or
amend in any manner whatsoever its health, dental, life and
disability insurance plans to accommodate the Executive,
although the Employer may make such modifications or amendments,
at its sole discretion, if it is consistent with the Employer's
developing employment policies.
Notwithstanding any other provision of this Section 2.5, in the event the
Severance Term is less than six (6) months and the employment of the Executive
is terminated as provided in the first paragraph of this Section 2.5, the
Executive shall receive (i) six (6) months of Base Salary as of the date of
termination of employment in equal payments over the six month period in
accordance with the Employer's customary wage payment practices and policies,
and (ii) six (6) months of group medical, dental and disability insurance at the
Employer Contribution Amount.
It is specifically acknowledged and agreed that (i) in the event Executive
resigns, Executive shall not be entitled to any Termination Payment, and (ii) in
the event Executive's employment is terminated by the Employer for any reason,
Executive shall not be entitled to a pro-rata cash incentive bonus as provided
in Section 2.2 of this Agreement.
In consideration for the payments provided in this Section 2.5, Executive agrees
to execute a release of any and all claims against the Employer, at the time of
termination of the Executive's employment, the release to be in such reasonable
form as prepared by the Employer.
2.6. RESTRICTED STOCK COMPENSATION. The Employer hereby grants to the Executive
that number of shares BVI common stock as determined by (a) multiplying the
Executive's Base Salary on the Commencement Date by 10%, then (b) multiplying
such amount by the sum of 3 plus the number of months remaining in fiscal year
1998 divided by 12, then (c) dividing such amount by the closing bid price
(hereinafter, the "Stock Price") of BVI common stock on the Commencement Date.
Such stock shall vest in four (4) installments on each of October 31, 1998,
1999, 2000 and 2001, as long as the Executive continues to be employed by the
Employer. The number of shares to vest on October 31, 1998 shall be the product
of (a) 10% of the Executive's Base Salary on the Commencement Date multiplied by
(b) the ratio of the number of months remaining in fiscal year 1998 by 12. The
remainder of such stock shall vest in three (3) equal installments on October
31, 1999, 2000 and 2001. Such stock will contain such restrictions or other
provisions as are applicable to other similarly circumstanced Executives issued
restrictive stock as part of their compensation plans.
2.7. STOCK OPTIONS.
(a) The Employer hereby grants to the Executive an option to
purchase that number of shares of BVI common stock as determined
by (a) multiplying the Executive's Base Salary on the
Commencement Date by 20%, then (b) multiplying such
-4-
<PAGE>
amount by the sum of 3 plus the number of months remaining in
fiscal year 1998 divided by 12, then (c) dividing such amount by
the Stock Price of BVI common stock on the Commencement Date.
Such option shall become exercisable in four increments on
October 31, 1998, 1999, 2000 and 2001, as long as the Executive
continues to be employed by the Employer. The number of shares
to become exercisable on October 31, 1998 shall be determined by
multiplying 20% of the Executive's Base Salary on the
Commencement Date by a fraction, the numerator of which is the
number of months remaining in fiscal year 1998, and the
denominator of which is 12. The remainder of such options will
become exercisable in equal installments on October 31, 1999,
2000 and 2001. The terms of the option will be governed by a
separate stock option agreement to be delivered at the time the
option is granted.
(b) On the Commencement Date the Employer will grant to the
Executive an option to purchase 7,000 shares of BVI common
stock. The terms of the option will be governed by a separate
stock option agreement to be delivered at the time the option is
granted. The option shall become exercisable on the fourth
anniversary of the Commencement Date, as long as the Executive
is employed by the Employer on the fourth anniversary of the
Commencement Date.
2.8. CHANGE IN CONTROL. The Executive shall be entitled to certain benefits upon
a change in control as defined in and in accordance with the terms of the Change
in Control Agreement attached hereto as Exhibit B.
-5-
<PAGE>
2.9 REIMBURSEMENT OF EXPENSES. The Employer shall reimburse the Executive for
all reasonable, ordinary and necessary expenses incurred by him in the
performance of his duties hereunder and the Executive shall account to the
Employer therefor in the manner normally prescribed by the Employer for
reimbursement of Executive expenses.
ARTICLE III.
DUTIES OF EXECUTIVE
3.1 SERVICES. The Executive shall perform all duties and obligations charged to
the Executive by the Board of Directors of the Employer, as the same may be
determined from time to time, provided, however, that it is acknowledged and
agreed that the President and Chief Executive Officer of BVI shall direct the
Executive's day-to-day activities. The Board shall assure adequate time,
resources and authority for the Executive to achieve goals mutually agreed upon
by the Employer and the Executive.
3.2 TIME AND EFFORT. The Executive shall devote his full time and effort to the
business of the Employer, provided, however, that Executive shall be allowed to
continue to serve as both (i) a member of an advisory group for U.M.C., Inc., a
private machine shop and (ii) a director of INNOVATIVE CUISINE, INCORPORATED
d/b/a FIVE STAR FOOD BASE COMPANY. The Executive shall perform the duties and
obligations required of the Executive hereunder in a competent, efficient and
satisfactory manner at such hours and under such conditions as the performance
of such duties and obligations may require.
3.3 ARTICLES AND BY-LAWS. The Executive shall act in accordance with and so as
to abide by the Articles of Incorporation of the Employer, the Bylaws of the
Employer and all decisions of the Board of Directors of the Employer.
3.4 CONFIDENTIALITY AND LOYALTY. Executive acknowledges that, during the course
of his employment he has produced and may produce and have access to material,
records, data and information not generally available to the public
("Confidential Information") regarding the Employer, its customers and
affiliates. Accordingly, during and subsequent to the termination of this
Agreement, Executive shall hold in confidence and not directly or indirectly
disclose, use, copy or make lists of any such confidential information, except
to the extent authorized in writing by the Employer, or as required by law or
any competent administrative agency or as otherwise is reasonably necessary or
appropriate in connection with the performance by Executive of his duties
pursuant to this Agreement. Upon termination of his employment under this
Agreement, Executive shall promptly deliver to the Employer (i) all records,
manuals, books, documents, letters, reports, data, tables, calculations and all
copies of any of the foregoing which are the property of Employer or which
relate in any way to the customers, business, practices or techniques of the
Employer and (ii) all other property of Employer and Confidential Information
which in any of these cases are in his possession or
-6-
<PAGE>
under his control. Executive agrees to abide by the Employer's reasonable
policies as in effect from time to time, respecting avoidance of interests
conflicting with those of the Employer.
3.5 COVENANT NOT TO COMPETE. In exchange for the consideration (i) received by
the Executive in accordance with the terms of the Merger Agreement and (ii)
given by Employer to Executive pursuant to this Agreement, specifically
including, but not limited to, the Severance Payment provided in Section 2.5 of
this Agreement, Executive agrees, represents to and covenants with the Employer
that during the period of Executive's employment by or with Employer, and for
the longer of (i) a period of one (1) year immediately following the termination
of Executive's employment with Employer under this Agreement or otherwise, and
(ii) ten (10) years following the Closing Date (as such term is defined in the
Merger Agreement), for any reason whatsoever, either directly or indirectly, for
himself or on behalf of or in conjunction with any other person, persons,
Employer, partnership, corporation or business of whatever nature violate the
noncompetition covenants of Article IX of the Merger Agreement, which are hereby
incorporated by reference in this Agreement in their entirety.
3.6. CREATIONS. Subject to Executive's rights under Minnesota Statutes ss.
181.78, Executive hereby agrees that every idea, concept, invention and
improvement (whether patented or not) conceived by Executive and all copyrighted
or copyrightable matter created by Executive that relates to the Employer's
business (collectively, "Creations") shall be the property of the Employer (or
its designee). Executive shall communicate promptly and disclose to the
Employer, in such form as the Employer may request, all information, details and
data pertaining to each Creation. Every copyrightable Creation, regardless of
whether copyright protection is sought or preserved by the Employer, shall be a
"work for hire" as defined in 12 U.S.C. ss. 101 and the Employer shall own all
rights in and to such matter throughout the world, without the payment of any
royalty or other consideration to Executive or anyone claiming through
Executive.
Executive shall execute and deliver to the Employer such formal transfers and
assignments and such other documents as the Employer may request to confirm and
protect the Employer's rights hereunder. Any idea, copyrightable matter or other
property relating to the Employer's business and disclosed by Executive or
discovered by the Employer prior to the first anniversary of the date of the
Executive's termination of employment (the "Termination Date") shall be deemed
to be governed hereby unless proved by Executive to have been first conceived
and made after the Termination Date.
3.7 CONFIDENTIALITY AND INSIDER TRADING AGREEMENTS. Concurrently with the
execution of this Agreement, Executive agrees to execute and deliver to the
Employer (i) the Executive Patent and Confidential Information Agreement and
(ii) the Statement of Policy regarding Insider Trading attached hereto as
Exhibits C and D, respectively.
3.8 REMEDIES. Executive agrees and understands that any breach of any of the
covenants
-7-
<PAGE>
or agreements set forth in this ARTICLE III of this Agreement will cause the
Employer irreparable harm for which there is no adequate remedy at law, and,
without limiting whatever other rights and remedies Employer may have under this
paragraph, Executive consents to the issuance of an injunction in favor of the
Employer enjoining the breach of any of the aforesaid covenants or agreements by
any court of competent jurisdiction. If any or all of the aforesaid covenants or
agreements are held to be unenforceable because of the scope or duration of such
covenant or agreement or the area covered thereby, the parties agree that the
court making such determination shall have the power to reduce or modify the
scope, duration and/or area of such covenant to the extent that allows the
maximum scope, duration and/or area permitted by applicable law.
ARTICLE IV.
TERMINATION
4.1 TERMINATION FOR CAUSE. Notwithstanding anything contained in this Agreement
to the contrary, the Employer shall have the right to terminate the employment
of the Executive upon the occurrence of any of the following events:
(a) The commission in the course of the Executive's employment by
the Employer of any fraudulent act;
(b) Conviction of a felony (from which, through lapse of time or
otherwise, no successful appeal shall have been made) whether or
not committed in the course of his employment by the Employer;
(c) The willful refusal to carry out reasonable instructions of the
Board; provided, however, that the Executive may only be
discharged after he shall have been given 30 days written notice
setting forth his alleged deficiencies and that he shall not,
within such 30-day period, have ceased or otherwise cured the
activity or activities or omission constituting the grounds for
termination;
(d) The willful disclosure of any trade secrets or confidential
corporate information of the Employer or BVI to persons not
authorized to know same, unless such disclosure is required by
any law or court order or similar process; and
(e) Inability of the Executive to perform the essential functions of
his duties in accordance with the terms of this Agreement, with
or without reasonable accommodation.
Where the employment of the Executive is terminated pursuant to this Article IV,
Section 4.1 of this Agreement, such termination shall be effective upon the
delivery of notice thereof to the
-8-
<PAGE>
Executive.
4.2 DEATH OF EXECUTIVE. In the event of Executive's death during the term of
this Agreement, this Agreement and the Employer's and the Executive's rights and
obligations under this Agreement shall terminate.
4.3 RESIGNATION OF EXECUTIVE. Executive may resign at any time for any reason
upon sixty (60) days advance written notice to the Chairman of the Board of
Directors provided that the Employer's obligations to the Executive, pursuant to
the terms of this Agreement, shall cease on the date the Executive's termination
is effective.
4.4. SURVIVING RIGHTS. Notwithstanding the termination of the Executive's
employment, the parties shall be required to carry out any provisions hereof
which contemplate performance subsequent to such termination; and such
termination shall not affect any liability or other obligation which shall have
accrued prior to such termination, including, but not limited to, any liability
for loss or damage on account of a prior default.
-9-
<PAGE>
ARTICLE V.
SETTLEMENT BY ARBITRATION
5.1 Arbitration Employer and Executive agree that any claim or controversy that
arises out of or relates to this Agreement, or the breach of it by either party,
will be settled by arbitration in the City of St. Paul, Minnesota in accordance
with the rules of the American Arbitration Association.
ARTICLE VI
INDEMNIFICATION
6.1 INDEMNIFICATION. Executive shall be entitled to indemnification and
advancement of expenses by reason of Executive's status with the Employer to the
fullest extent permitted under the laws of the State of Minnesota and the
Articles of Incorporation and bylaws of the Employer, and likewise, shall be
entitled to indemnification and advancement of expenses by reason of Executive's
status with Employer to the fullest extent permitted under the laws of the State
of Minnesota and Articles of Incorporation and bylaws of Employer. The Employer
represents to the Executive that as of the date hereof there is no provision of
the Articles of Incorporation or bylaws of the Employer that prohibits or limits
indemnification or advances of expenses or imposes conditions on indemnification
or advances of expenses in addition to the conditions set forth in Minnesota
law.
ARTICLE VII.
GENERAL PROVISIONS
7.1 NOTICES. All notices, requests, and other communications shall be in writing
and except as otherwise provided herein, shall be considered to have been
delivered if personally delivered or when deposited in the United States Mail,
first class, certified or registered, postage prepaid, return receipt requested,
addressed to the proper party at its address as set forth below, or to such
other address as such party may hereafter designate by written notice to the
other party:
(a) If to the Employer, to: M. Karen Gilles
Bio-Vascular, Inc.
2575 University Avenue
St. Paul, MN 55114-1024
With a copy to: Richard A. Hoel, Esq.
Winthrop & Weinstine
3000 Dain Rauscher Plaza
-10-
<PAGE>
60 South 6th Street
Minneapolis, MN 55402-4430
(b) If to the Executive, to: James F. Pfau
1788 Fremont Avenue South
Minneapolis, MN 55403
With a copy to: David R. Busch
1100 International Centre
900 Second Avenue South
Minneapolis, MN 55402
7.2 WAIVER, MODIFICATION OR AMENDMENT. No waiver, modification or amendment of
any term, condition or provision of this Agreement shall be valid or of any
effect unless made in writing, signed by the party to be bound or its duly
authorized representative and specifying with particularity the nature and
extent of such waiver, modification or amendment. Any waiver by any party of any
default of the other shall not effect, or impair any right arising from, any
subsequent default. Nothing herein shall limit the rights and remedies of the
parties hereto under and pursuant to this Agreement, except as hereinbefore set
forth.
7.3 ENTIRE AGREEMENT. This Agreement contains the entire understanding of the
parties hereto in respect of transactions contemplated hereby and supersedes all
prior agreements and understandings between the parties with respect to such
subject matter.
7.4 INTERPRETATION AND SEVERANCE. The provisions of this Agreement shall be
applied and interpreted in a manner consistent with each other so as to carry
out the purposes and intent of the parties hereto, but if for any reason any
provision hereof is determined to be unenforceable or invalid, such provision or
such part thereof as may be unenforceable or invalid shall be deemed severed
from this Agreement and the remaining provisions shall be carried out with the
same force and effect as if the severed provision or part thereof had not been a
part of this Agreement.
7.5 GOVERNING LAW. This Agreement shall be construed and enforced in accordance
with the laws of the State of Minnesota.
7.6 SUCCESSORS AND ASSIGNS/OBLIGATIONS OF EMPLOYER. This Agreement shall be
binding upon the Employer and its successors and assigns and shall inure to the
benefit of the Executive and the Executive's heirs, executors and
administrators.
7.7 IDENTICAL COUNTERPARTS. This Agreement may be executed in one or more
counterparts, each of which shall for all purposes be deemed to be an original
but all of which shall constitute one and the same Agreement.
-11-
<PAGE>
7.8 BVI GUARANTEE. BVI guarantees any and all obligations of the Employer in
accordance with the terms of this Agreement.
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the
day and year first above written.
JER-NEEN MANUFACTURING CO., INC.
By ___________________________
Its __________________________
BIO-VASCULAR, INC.
By ___________________________
Its __________________________
EXECUTIVE:
_______________________________
James F. Pfau
-12-
<PAGE>
EXHIBIT A
Allocation of Annual Cash Incentive to be paid to Executive in accordance with
Section 2.2 of Executive's Employment Agreement to which this Exhibit A is
attached hereof.
PERCENT
ALLOCATION
Achievement of Personal Management by Objectives
("MBO") Goals as determined by the Employer 20%
Employer Performance Goals:
Operating Income 40%
Net Revenue 40% 80%
--- ---
Total Allocation 100%
===
For example, without limitation, assuming a Base Salary of $100,000 and the
Board determines that Executive has met all his MBO goals and the Employer has
met its Operating Income and Net Revenue goals, then Executive would receive
$20,000 ($100,000 X 20%). However, if the Board determines that the Executive
has met all his MBO goals, and the Employer has not met 100% of its Operating
Income and its Net Revenue goals, the Executive would receive $4,000 ($100,000 X
20% X 20%), only that incentive due related to MBO's. Likewise, if the Board
determines that the Executive has met only 75% of his MBO goals (and the
Employer has not met either of its Performance Goals) the Executive would
receive $3,000 (100,000 x 20% x 20% x75%).
-13-
<PAGE>
EXHIBIT 10.2
CHANGE IN CONTROL AGREEMENT
---------------------------
July 31, 1998
Mr. James F. Pfau
1788 Fremont Avenue South
Minneapolis, MN 55403
Dear Mr. Pfau:
You are presently the President of Jer-Neen Manufacturing Co., Inc., an
Affiliate of Bio-Vascular, Inc., a Minnesota corporation (the "Company"). The
Company considers the establishment and maintenance of a sound and vital
management to be essential to protecting and enhancing the best interests of the
Company and its shareholders. In this connection, the Company recognizes that,
as is the case with many publicly held corporations, the possibility of a Change
in Control may arise and that such possibility and the uncertainty and questions
which it may raise among management may result in the departure or distraction
of management personnel to the detriment of the Company and its shareholders.
Accordingly, the Board has determined that appropriate steps should be taken to
minimize the risk that Company management will depart prior to a Change in
Control, thereby leaving the Company without adequate management personnel
during such a critical period, and that appropriate steps also be taken to
reinforce and encourage the continued attention and dedication of members of the
Company's management to their assigned duties without distraction in
circumstances arising from the possibility of a Change in Control. In
particular, the Board believes it important, should the Company or its
shareholders receive a proposal for transfer of control, that you be able to
continue your management responsibilities without being influenced by the
uncertainties of your own personal situation.
The Board recognizes that continuance of your position with the Company involves
a substantial commitment to the Company in terms of your personal life and
professional career and the possibility of foregoing present and future career
opportunities, for which the Company receives substantial benefits. Therefore,
to induce you to remain in the employ of the Company, this Agreement, which has
been approved by the Board, sets forth the benefits which the Company agrees
will be provided to you in the event your employment with the Company is
terminated in connection with a Change in Control under the circumstances
described below.
The following terms will have the meaning set forth below unless the context
clearly requires otherwise. Terms defined elsewhere in this Agreement will have
the same meaning throughout this Agreement.
<PAGE>
Mr. James F. Pfau
Page 2
ARTICLE I.
DEFINITIONS
1. "Affiliate" means (i) any corporation at least a majority of whose
outstanding securities ordinarily having the right to vote at elections
of directors is owned directly or indirectly by the Company or (ii) any
other form of business entity in which the Company, by virtue of a
direct or indirect ownership interest, has the right to elect a
majority of the members of such entity's governing body.
2. "Agreement" means this letter agreement as amended, extended or renewed
from time to time in accordance with its terms.
3. "Board" means the board of directors of the Company duly qualified and
acting at the time in question. On and after the date of a Change in
Control, any duty of the Board in connection with this Agreement is
nondelegable and any attempt by the Board to delegate any such duty is
ineffective.
4. "Cause" means:
a. your gross misconduct;
b. your willful and continued failure to perform substantially your
duties with the Company (other than any such failure (1)
resulting from your Disability or incapacity due to bodily injury
or physical or mental illness or (2) relating to changes in your
duties after a Change in Control which constitute Good Reason)
after a demand for substantial performance is delivered to you by
the chair of the Board which specifically identifies the manner
in which you have not substantially performed your duties and
provides for a reasonable period of time within which you may
take corrective actions; or
c. your conviction (including a plea of nolo contendere) of
willfully engaging in illegal conduct constituting a felony or
gross misdemeanor under federal or state law which is materially
and demonstrably injurious to the Company or which impairs your
ability to perform substantially your duties for the Company.
An act or failure to act will be considered "gross" or "willful" for
this purpose only if done, or omitted to be done, by you in bad faith
and without reasonable belief that it was in, or not opposed to, the
best interests of the Company. Any act, or failure to act, based upon
authority given pursuant to a resolution duly adopted by the Company's
board of directors (or a committee thereof) or based upon the advice of
counsel for the Company will be conclusively presumed to be done, or
omitted to be done, by you in good faith and in the best interests of
the Company. It is also expressly understood that your attention to
matters not directly related to the business of the Company will not
provide a basis for termination for Cause so long as the Board did not
expressly disapprove in writing of your engagement in such activities
either before or within a reasonable period of time after the Board
knew or could reasonably have known that you engaged in those
activities. Notwithstanding the foregoing, you may not be terminated
for Cause unless and until there has been delivered to
<PAGE>
Mr. James F. Pfau
Page 3
you a copy of a resolution duly adopted by the affirmative vote of not
less than a majority of the entire membership of the Board at a meeting
of the Board called and held for the purpose (after reasonable notice
to you and an opportunity for you, together with your counsel, to be
heard before the Board), finding that in the good faith opinion of the
Board you were guilty of the conduct set forth above in clauses a., b.
or c. of this definition and specifying the particulars thereof in
detail.
5. "Change in Control" means any of the following:
a. the sale, lease, exchange or other transfer, directly or
indirectly, of all or substantially all of the assets of the
Company in one transaction or in a series of related
transactions, to any Person;
b. the approval by the shareholders of the Company of any plan or
proposal for the liquidation or dissolution of the Company, as
the case may be;
c. any Person is or becomes the "beneficial owner" (as defined in
Rule 13d-3 under the Exchange Act), directly or indirectly, of
(1) 20 percent or more, but not more than 50 percent, of the
combined voting power of the outstanding securities of the
Company ordinarily having the right to vote at elections of
directors, unless the transaction resulting in such ownership has
been approved in advance by the "continuity directors" or (2)
more than 50 percent of the combined voting power of the
outstanding securities of the Company ordinarily having the right
to vote at elections of directors (regardless of any approval by
the continuity directors);
d. a merger or consolidation to which the Company is a party if the
shareholders of the Company immediately prior to the effective
date of such merger or consolidation have, solely on account of
ownership of securities of the Company at such time, "beneficial
ownership" (as defined in Rule 13d-3 under the Exchange Act)
immediately following the effective date of such merger or
consolidation of securities of the surviving company representing
(1) 50 percent or more, but not more than 80 percent, of the
combined voting power of the surviving corporation's then
outstanding securities ordinarily having the right to vote at
elections of directors, unless such merger or consolidation has
been approved in advance by the continuity directors, or (2) less
than 50 percent of the combined voting power of the surviving
corporation's then outstanding securities ordinarily having the
right to vote at elections of directors (regardless of any
approval by the continuity directors);
e. the continuity directors cease for any reason to constitute at
least a majority the Board; or
f. a change in control of a nature that is determined by outside
legal counsel to the Company, in a written opinion specifically
referencing this provision of the Agreement, to be required to be
reported (assuming such event has not been
<PAGE>
Mr. James Pfau
Page 4
"previously reported") pursuant to section 13 or 15(d) of the
Exchange Act, whether or not the Company is then subject to such
reporting requirement, as of the effective date of such change in
control.
For purposes of this Section 1(e), a "continuity director" means any
individual who is a member of the Board on July 31, 1998, while he or
she is a member of the Board, and any individual who subsequently
becomes a member of the Board whose election or nomination for election
by the Company's shareholders was approved by a vote of at least a
majority of the directors who are continuity directors (either by a
specific vote or by approval of the proxy statement of the Company in
which such individual is named as a nominee for director without
objection to such nomination).
6. "Code" means the Internal Revenue Code of 1986, as amended. Any
reference to a specific provision of the Code includes a reference to
such provision as it may be amended from time to time and to any
successor provision.
7. "Company" means Bio-Vascular, Inc. and/or any Affiliate.
8. "Confidential Information" means information which is proprietary to
the Company or proprietary to others and entrusted to the Company,
whether or not trade secrets. It includes information relating to
business plans and to business as conducted or anticipated to be
conducted, and to past or current or anticipated products or services.
It also includes, without limitation, information concerning research,
development, purchasing, accounting, marketing and selling. All
information which you have a reasonable basis to consider confidential
is Confidential Information, whether or not originated by you and
without regard to the manner in which you obtain access to that and any
other proprietary information.
9. "Date of Termination" following a Change in Control (or prior to a
Change in Control if your termination was either a condition of the
Change in Control or was at the request or insistence of any Person
related to the Change in Control) means:
a. if your employment is to be terminated for Disability, 30 days
after Notice of Termination is given (provided that you have not
returned to the performance of your duties on a full-time basis
during such 30-day period);
b. if your employment is to be terminated by the Company for Cause
or by you for Good Reason, the date specified in the Notice of
Termination, which date may not be less than 30 days or more than
60 days after the date on which the Notice of Termination is
given unless you and the Company otherwise expressly agree;
c. if your employment is to be terminated by the Company for any
reason other than Cause, Disability, death or Retirement, the
date specified in the Notice of Termination, which in no event
may be a date earlier than 90 days after the date on
<PAGE>
Mr. James Pfau
Page 5
which a Notice of Termination is given, unless an earlier date
has been expressly agreed to by you in writing either in advance
of, or after; receiving such Notice of Termination; or
d. if your employment is terminated by reason of death or
Retirement, the date of death or Retirement, respectively.
In the case of termination by the Company of your employment for Cause,
if you have not previously expressly agreed in writing to the
termination, then within 30 days after receipt by you of the Notice of
Termination with respect thereto, you may notify the Company that a
dispute exists concerning the termination, in which event the Date of
Termination will be the date set either by mutual written agreement of
the parties or by the judge or arbitrators in a proceeding as provided
in Section 13 of this Agreement. During the pendency of any such
dispute, you will continue to make yourself available to provide
services to the Company and the Company will continue to pay you your
full compensation and benefits in effect immediately prior to the date
on which the Notice of Termination is given (without regard to any
changes to such compensation or benefits which constitute Good Reason)
and until the dispute is resolved in accordance with Section 13 of this
Agreement. You will be entitled to retain the full amount of any such
compensation and benefits without regard to the resolution of the
dispute unless the judge or arbitrators decide(s) that your claim of a
dispute was frivolous or advanced by you in bad faith.
10. "Disability" means a disability as defined in the Company's long-term
disability plan as in effect immediately prior to the Change in Control
or; in the absence of such a plan, means permanent and total disability
as defined in section 22(e)(3) of the Code.
11. "ExchangeAct" means the Securities Exchange Act of 1934, as amended.
Any reference to a specific provision of the Exchange Act or to any
rule or regulation thereunder includes a reference to such provision as
it may be amended from time to time and to any successor provision.
12. "Good Reason" means:
a. change in your status, position(s), duties or responsibilities as
an executive of the Company as in effect immediately prior to the
Change in Control which, in your reasonable judgment, is an
adverse change (other than, if applicable, any such change
directly attributable to the fact that the Company is no longer
publicly owned) except in connection with the termination of your
employment for Cause, Disability or Retirement or as a result of
your death or by you other than for Good Reason;
b. a reduction by the Company in your base salary (or an adverse
change in the form or timing of the payment thereof) as in effect
immediately prior to the Change in Control or as thereafter
increased;
<PAGE>
Mr. James Pfau
Page 6
c. the failure by the Company to continue in effect any Plan in
which you (and/or your family) are eligible to participate at any
time during the 90-day period immediately preceding the Change in
Control (or Plans providing you (and/or your family) with at
least substantially similar benefits) other than as a result of
the normal expiration of any such Plan in accordance with its
terms as in effect immediately prior to the 90-day period
immediately preceding the time of the Change in Control, or the
taking of any action, or the failure to act, by the Company which
would adversely affect your (and/or your family's) continued
eligibility to participate in any of such Plans on at least as
favorable a basis to you (and/or your family) as is the case on
the date of the Change in Control or which would materially
reduce your (and/or your family's) benefits in the future under
any of such Plans or deprive you (and/or your family) of any
material benefit enjoyed by you (and/or your family) at the time
of the Change in Control;
d. the Company's requiring you to be based more than 30 miles from
where your office is located immediately prior to the Change in
Control, except for required travel on the Company's business,
and then only to the extent substantially consistent with the
business travel obligations which you undertook on behalf of the
Company during the 90-day period immediately preceding the Change
in Control (without regard to travel related to or in
anticipation of the Change in Control);
e. the failure by the Company to obtain from any Successor the
assent to this Agreement contemplated by Section 6 of this
Agreement;
f. any purported termination by the Company of your employment which
is not properly effected pursuant to a Notice of Termination and
pursuant to any other requirements of this Agreement, and for
purposes of this Agreement, no such purported termination will be
effective;
g. any refusal by the Company to continue to allow you to attend to
matters or engage in activities not directly related to the
business of the Company which, at any time prior to the Change in
Control, you were not expressly prohibited in writing by the
Board from attending to or engaging in; or
h. your termination of your employment with the Company for any
reason other than death, Disability or Retirement during the
twelfth (12th) month following the month in which a Change in
Control occurs.
13. "Highest Monthly Compensation" means one-twelfth of the highest amount
of your compensation for any 12 consecutive calendar-month period
during the 36 consecutive calendar-month period prior to the month that
includes the Date of Termination. For purposes of this definition,
"compensation" means the amount reportable by the Company, for federal
income tax purposes, as wages paid to you by the Company, increased by
the amount of contributions made by the Company with respect to you
under any qualified cash
<PAGE>
Mr. James Pfau
Page 7
or deferred arrangement or cafeteria plan that is not then includable
in your income by reason of the operation of section 402(a)(8) or
section 125 of the Code, and increased further by any other
compensation deferred for any reason.
14. "Notice of Termination" means a written notice given on or after the
date of a Change in Control (unless your termination before the date of
the Change in Control was either a condition of the Change in Control
or was at the request or insistence of any Person related to the Change
in Control) which indicates the specific termination provision in this
Agreement pursuant to which the notice is given. Any purported
termination by the Company or by you for Good Reason on or after the
date of a Change in Control (or before the date of a Change in Control
if your termination was either a condition of the Change in Control or
was at the request or insistence of any Person related to the Change in
Control) must be communicated by written Notice of Termination to be
effective; provided, that your failure to provide Notice of Termination
will not limit any of your rights under this Agreement except to the
extent the Company demonstrates that it suffered material actual
damages by reason of such failure.
15. "Person" means any individual, corporation, partnership, group,
association or other "person," as such term is used in section 14(d) of
the Exchange Act, other than the Company, any Affiliate or any employee
benefit plan(s) sponsored by the Company or an Affiliate.
16. "Plan" means any compensation plan, program, policy or agreement (such
as a stock option, restricted stock plan or other equity-based plan),
any bonus or incentive compensation plan, program, policy or agreement,
any employee benefit plan, program, policy or agreement (such as a
thrift, pension, profit sharing, medical, dental, disability, accident,
life insurance, relocation, salary continuation, expense
reimbursements, vacation, fringe benefits, office and support staff
plan or policy) or any other plan, program, policy or agreement of the
Company intended to benefit employees (and/or their families)
generally, management employees (and/or their families) as a group or
you (and/or your family) in particular.
17. "Retirement" means termination of employment on or after the day on
which you attain the age of 65.
18. "Successor" means any Person that succeeds to, or has the practical
ability to control (either immediately or solely with the passage of
time), the Company's business directly, by merger, consolidation or
other form of business combination, or indirectly, by purchase of the
Company's outstanding securities ordinarily having the right to vote at
the election of directors or, all or substantially all of its assets or
otherwise.
<PAGE>
Mr. James Pfau
Page 8
ARTICLE II.
TERM OF AGREEMENT
This Agreement is effective immediately and will continue in effect until July
30, 1999; provided, however; that commencing on July 31, 1999 and each July 31st
thereafter, the term of this Agreement will automatically be extended for 12
additional months beyond the expiration date otherwise then in effect, unless at
least 90 calendar days prior to any such July 31, the Company or you has given
notice that this Agreement will not be extended; and, provided, further; that if
a Change in Control has occurred during the term of this Agreement, this
Agreement will continue in effect beyond the termination date then in effect for
a period of 12 months following the month during which the Change in Control
occurs or, if later, until the date on which the Company's obligations to you
arising under or in connection with this Agreement have been satisfied in full.
ARTICLE III.
CHANGE IN CONTROL BENEFITS
1. Benefits upon a Change in Control Termination. You will become entitled
to the payments and benefits described in clauses (a) and (b) of this
Article III., subject to the limitations described in clause (c) of
this Article III., and to the benefit of the provisions described in
clause (d), if and only if (i) your employment with the Company is
terminated for any reason other than death, Cause, Disability or
Retirement, or if you terminate your employment with the Company for
Good Reason; and (ii) the termination occurs either within the period
beginning on the date of a Change in Control and ending on the last day
of the twelfth month that begins after the month during which the
Change in Control occurs or prior to a Change in Control if your
termination was either a condition of the Change in Control or was at
the request or insistence of a Person related to the Change in Control.
a. Cash Payment. Within five business days following the Date of
Termination or, if later, within five business days following the
date of the Change in Control, the Company will make a lump-sum
cash payment to you in an amount equal to the product of (i) your
Highest Monthly Compensation multiplied by (ii) 36.
b. Welfare Plans. The Company will maintain in full force and
effect, for the continued benefit of you and your dependents for
a period terminating 36 months after the Date of Termination, all
insured and self-insured employee welfare benefit Plans
(including, without limitation, medical, life, dental, vision and
disability plans) in which you were eligible to participate at
any time during the 90-day period immediately preceding the
Change in Control, provided that your continued participation is
possible under the general terms and provisions of such Plans and
any applicable funding media and without regard to any
discretionary amendments to such Plans by the Company following
the Change in Control (or prior to the Change in Control if
amended as a condition or at the request or insistence of a
Person (other than the Company) related to the Change in Control)
and provided that you continue to pay an amount equal to your
regular contribution under such
<PAGE>
Mr. James Pfau
Page 9
Plans for such participation (based upon your level of benefits
and employment status most favorable to you at any time during
the 90-day period immediately preceding the Change in Control).
The continuation period under federal and state continuation
laws, to the extent applicable, will begin to run from the date
on which coverage pursuant to this clause (b) ends. If, at the
end of the 36-month period, you have not previously received or
are not then receiving equivalent benefits from a new employer
(including coverage for any pre-existing conditions), the Company
will arrange, at its sole cost and expense, to enable you to
convert your and your dependents' coverage under such Plans to
individual policies or programs upon the same terms as executives
of the Company may apply for such conversions. In the event that
your or your dependents' participation in any such Plan is
barred, the Company, at its sole cost and expense, will arrange
to have issued for the benefit of you and your dependents
individual policies of insurance providing benefits substantially
similar (on a federal, state and local income and employment
after-tax basis) to those which you otherwise would have been
entitled to receive under such Plans pursuant to this clause (b)
or; if such insurance is not available at a reasonable cost to
the Company, the Company will otherwise provide you and your
dependents equivalent benefits (on a federal, state and local
income and employment after-tax basis). You will not be required
to pay any premiums or other charges in an amount greater than
that which you would have paid in order to participate in such
Plans.
c. Limitation on Payments and Benefits. Notwithstanding anything in
this Agreement to the contrary, if any of the payments or
benefits to be made or provided in connection with this
Agreement, together with any other payments, benefits or awards
which you have the right to receive from the Company, or any
corporation which is a member of an "affiliated group" (as
defined in section 1504(a) of the Code without regard to section
1504(b) of the Code) of which the Company is a member
("Affiliate"), constitute an "excess parachute payment" (as
defined in section 280G(b) of the Code), such payments, benefits
or awards to be made or provided in connection with this
Agreement, or any other agreement between you and the Company or
its Affiliates, may be reduced, eliminated, modified or waived to
the extent necessary to prevent all, or any portion, of such
payments, benefits or awards from becoming "excess parachute
payments" and therefore subject to the excise tax imposed under
section 4999 of the Code. You will have the sole right and
discretion to determine whether the payments, benefits or awards
to be made or provided in connection with this Agreement, or any
other agreement between you and the Company, should be reduced,
whether or not such other agreement with the Company or an
Affiliate expressly addresses the potential application of
Sections 280G or 4999 of the Code (including, without limitation,
that "payments" under such agreement be reduced). You will also
have the right to designate the particular payments, benefits or
awards that are to be reduced, eliminated, modified or waived;
provided that no such adjustment will be made if it results in
additional expense to the Company in excess of expenses the
Company would have experienced if no
<PAGE>
Mr. James Pfau
Page 10
adjustment had been made. The determination as to whether any
such decrease in the payments or benefits is necessary must be
made in good faith by legal counsel or a certified public
accountant selected by you and reasonably acceptable to the
Company, and such determination will be conclusive and binding
upon you and the Company. The Company will pay or reimburse you
on demand for the reasonable fees, costs and expenses of the
counsel or accountant selected to make the determinations under
this clause (c).
2. Disposition. If, on or after the date of a Change in Control, an
Affiliate is sold, merged, transferred or in any other manner or for
any other reason ceases to be an Affiliate or all or any portion of the
business or assets of an Affiliate are sold, transferred or otherwise
disposed of and the acquiror is not the Company or an Affiliate (a
"Disposition"), and you remain or become employed by the acquiror or an
affiliate of the acquiror (as defined in this Agreement but
substituting "acquiror" for "Company") in connection with the
Disposition, you will be deemed to have terminated employment on the
effective date of the Disposition for purposes of this section unless
(a) the acquiror and its affiliates jointly and severally expressly
assume and agree, in a manner that is enforceable by you, to perform
the obligations of this Agreement to the same extent that the Company
would be required to perform if the Disposition had not occurred and
(b) the Successor guarantees, in a manner that is enforceable by you,
payment and performance by the acquirer.
ARTICLE IV.
INDEMNIFICATION
Following a Change in Control, the Company will indemnify and advance expenses
to you to the full extent permitted by law and the Company's articles of
incorporation and bylaws for damages, costs and expenses (including, without
limitation, judgments, fines, penalties, settlements and reasonable fees and
expenses of your counsel) incurred in connection with all matters, events and
transactions relating to your service to or status with the Company or any other
corporation, employee benefit plan or other entity with whom you served at the
request of the Company.
ARTICLE V.
CONFIDENTIALITY
You will not use, other than in connection with your employment with the
Company, or disclose any Confidential Information to any person not employed by
the Company or not authorized by the Company to receive such Confidential
Information, without the prior written consent of the Company; and you will use
reasonable and prudent care to safeguard and protect and prevent the
unauthorized disclosure of Confidential Information. Nothing in this Agreement
will prevent you from using, disclosing or authorizing the disclosure of any
Confidential Information: (a) which is or hereafter becomes part of the public
domain or otherwise becomes generally available to the public through no fault
of yours; (b) to the extent and upon the terms and conditions that the Company
may have previously made the Confidential Information available to certain
persons; or (c) to the
<PAGE>
Mr. James Pfau
Page 11
extent that you are required to disclose such Confidential Information by law or
judicial or administrative process.
ARTICLE VI.
SUCCESSORS
The Company will seek to have any Successor, by agreement in form and substance
satisfactory to you, assent to the fulfillment by the Company of the Company's
obligations under this Agreement. Failure of the Company to obtain such assent
at least three business days prior to the time a Person becomes a Successor (or
where the Company does not have at least three business days' advance notice
that a Person may become a Successor, within one business day after having
notice that such Person may become or has become a Successor) will constitute
Good Reason for termination by you of your employment. The date on which any
such succession becomes effective will be deemed the Date of Termination and
Notice of Termination will be deemed to have been given on that date. A
Successor has no rights, authority or power with respect to this Agreement prior
to a Change in Control.
ARTICLE VII.
OTHER PROVISIONS
1. Fees and Expenses. The Company, upon demand, will pay or reimburse you
for all reasonable legal fees, court costs, experts' fees and related
costs and expenses incurred by you in connection with any actual,
threatened or contemplated litigation or legal, administrative,
arbitration or other proceeding relating to this Agreement to which you
are or reasonably expect to become a party, whether or not initiated by
you, including, without limitation: (a) all such fees and expenses, if
any, incurred in contesting or disputing any such termination; or (b)
your seeking to obtain or enforce any right or benefit provided by this
Agreement; provided, however; you will be required to repay (without
interest) any such amounts to the Company to the extent that a court
issues a final and non-appealable order setting forth the determination
that the position taken by you was frivolous or advanced by you in bad
faith.
2. Binding Agreement. This Agreement inures to the benefit of, and is
enforceable by, you, your personal and legal representatives,
executors, administrators, successors, heirs, distributees, devisees
and legatees. If you die while any amount would still be payable to you
under this Agreement if you had continued to live, all such amounts,
unless otherwise provided in this Agreement, will be paid in accordance
with the terms of this Agreement to your devisee, legatee or other
designee or; if there be no such designee, to your estate.
3. No Mitigation. You will not be required to mitigate the amount of any
payments or benefits the Company becomes obligated to make or provide
to you in connection with this Agreement by seeking other employment or
otherwise. The payments or benefits to be made or provided to you in
connection with this Agreement may not be reduced, offset or
<PAGE>
Mr. James Pfau
Page 12
subject to recovery by the Company by any payments or benefits you may
receive from other employment or otherwise.
4. No Setoff. The Company has no right to setoff payments or benefits owed
to you under this Agreement against amounts owed or claimed to be owed
by you to the Company under this Agreement or otherwise.
5. Taxes. All payments and benefits to be made or provided to you in
connection with this Agreement will be subject to required withholding
of federal, state and local income, excise and employment-related
taxes.
6. Notices. For the purposes of this Agreement, notices and all other
communications provided for in, or required under, this Agreement must
be in writing and will be deemed to have been duly given when
personally delivered or when mailed by United States registered or
certified mail, return receipt requested, postage prepaid and addressed
to each party's respective address set forth on the first page of this
Agreement (provided that all notices to the Company must be directed to
the attention of the chair of the Board), or to such other address as
either party may have furnished to the other in writing in accordance
with these provisions, except that notice of change of address will be
effective only upon receipt.
7. Disputes.If you so elect, any dispute, controversy or claim arising
under or in connection with this Agreement will be settled exclusively
by binding arbitration administered by the American Arbitration
Association in Minneapolis, Minnesota in accordance with the Commercial
Arbitration Rules of the American Arbitration Association then in
effect. Judgment may be entered on the arbitrator's award in any court
having jurisdiction; provided, that you may seek specific performance
of your right to receive payment or benefits until the Date of
Termination during the pendency of any dispute or controversy arising
under or in connection with this Agreement. The Company will be
entitled to seek an injunction or restraining order in a court of
competent jurisdiction (within or without the State of Minnesota) to
enforce the provisions of Section 5 of this Agreement.
8. Jurisdiction. Except as specifically provided otherwise in this
Agreement, the parties agree that any action or proceeding arising
under or in connection with this Agreement must be brought in a court
of competent jurisdiction in the State of Minnesota, and hereby consent
to the exclusive jurisdiction of said courts for this purpose and agree
not to assert that such courts are an inconvenient forum.
9. Related Agreements. To the extent that any provision of any other Plan
or agreement between the Company and you limits, qualifies or is
inconsistent with any provision of this Agreement, then for purposes of
this Agreement, while such other Plan or agreement remains in force,
the provision of this Agreement will control and such provision of such
other Plan or agreement will be deemed to have been superseded, and to
be of no force or effect, as if such other agreement had been formally
amended to the extent necessary to accomplish such purpose. Nothing in
this Agreement prevents or limits your continuing or
<PAGE>
Mr. James Pfau
Page 13
future participation in any Plan provided by the Company and for which
you may qualify, and nothing in this Agreement limits or otherwise
affects the rights you may have under any Plans or other agreements
with the Company. Amounts which are vested benefits or which you are
otherwise entitled to receive under any Plan or other agreement with
the Company at or subsequent to the Date of Termination will be payable
in accordance with such Plan or other agreement.
10. No Employment or Service Contract. Nothing in this Agreement is
intended to provide you with any right to continue in the employ of the
Company for any period of specific duration or interfere with or
otherwise restrict in any way your rights or the rights of the Company,
which rights are hereby expressly reserved by each, to terminate your
employment at any time for any reason or no reason whatsoever, with or
without cause.
11. Funding and Payment. Benefits payable under this Agreement will be paid
only from the general assets of the Company. No person has any right to
or interest in any specific assets of the Company by reason of this
Agreement. To the extent benefits under this Agreement are not paid
when due to any individual, he or she is a general unsecured creditor
of the Company with respect to any amounts due. The Company with whom
you were employed immediately before your Date of Termination has
primary responsibility for benefits to which you or any other person
are entitled pursuant to this Agreement but to the extent such Company
is unable or unwilling to provide such benefits, the Company and each
other Affiliate are jointly and severally responsible therefor to the
extent permitted by applicable law. If you were simultaneously employed
by more than one Company immediately before your Date of Termination,
each such Company has primary responsibility for a portion of the
benefits to which you or any other person are entitled pursuant to this
Agreement that bears the same ratio to the total benefits to which you
or such other person are entitled pursuant to this Agreement as your
base pay from the Company immediately before your Date of Termination
bears to your aggregate base pay from all such Companies.
12. Survival.The respective obligations of, and benefits afforded to, the
Company and you which by their express terms or clear intent survive
termination of your employment with the Company or termination of this
Agreement, as the case may be, including without limitation the
provisions of Articles III, IV, V and VI and Sections 1, 4, 5, 6 and 7
of Article VII of this Agreement, will survive termination of your
employment with the Company or termination of this Agreement, as the
case may be, and will remain in full force and effect according to
their terms.
ARTICLE VIII.
MISCELLANEOUS
1. Modification and Waiver. No provision of this Agreement may be
modified, waived or discharged unless such modification, waiver or
discharge is agreed to in a writing signed by you and the chair of the
Board. No waiver by any party to this Agreement at any time of any
breach by another party to this Agreement of, or of compliance with,
any condition or
<PAGE>
Mr. James Pfau
Page 14
provision of this Agreement to be performed by such party will be
deemed a waiver of similar or dissimilar provisions or conditions at
the same or at any prior or subsequent time.
2. Entire Agreement. No agreements or representations, oral or otherwise,
express or implied, with respect to the subject matter to this
Agreement have been made by any party which are not expressly set forth
in this Agreement.
3. GoverningLaw. This Agreement and the legal relations among the parties
as to all matters, including, without limitation, matters of validity,
interpretation, construction, performance and remedies, will be
governed by and construed exclusively in accordance with the internal
laws of the State of Minnesota (without regard to the conflict of laws
principles of any jurisdiction).
4. Headings. Headings are for purposes of convenience only and do not
constitute a part of this Agreement.
5. Further Acts. The parties to this Agreement agree to perform, or cause
to be performed, such further acts and deeds and to execute and deliver
or cause to be executed and delivered, such additional or supplemental
documents or instruments as may be reasonably required by the other
party to carry into effect the intent and purpose of this Agreement.
6. Severability. The invalidity or unenforceability of all or any part of
any provision of this Agreement will not affect the validity or
enforceability of the remainder of such provision or of any other
provision of this Agreement, which will remain in full force and
effect.
7. Counterparts. This Agreement may be executed in several counterparts,
each of which will be deemed to be an original, but all of which
together will constitute one and the same instrument.
<PAGE>
Mr. James Pfau
Page 15
If this letter correctly sets forth our agreement on the subject matter
discussed above, kindly sign and return to the Company the enclosed copy of this
letter which will then constitute our agreement on this subject.
Sincerely,
BIO-VASCULAR, INC.
By:
----------------------------------
Name:
--------------------------------
Title:
-------------------------------
Agreed to this 31st day of July, 1998.
-----------------------------------
James F. Pfau
<PAGE>
EXHIBIT 99.1
FROM: FOR:
Swenson NHB Investor Relations Bio-Vascular, Inc.
1300 Fifth Street Towers, 150 S. 5th St. 2575 University Ave.
Minneapolis, Minn. 55402 St. Paul, Minn. 55114
Contact-Curt Swenson 612/371-0000 Connie L. Magnuson, CFO 612/603-3700
FOR IMMEDIATE RELEASE
BIO-VASCULAR SIGNS LETTER OF INTENT
TO ACQUIRE JER-NEEN MANUFACTURING CO.
St. Paul, Minn., June 2 - Bio-Vascular, Inc. (Nasdaq:BVAS) announced
today that it has entered into a letter of intent to purchase all of the
outstanding shares of Jer-Neen Manufacturing Company, Inc. Terms were not
disclosed. Completion of the transaction is contingent upon execution of a
definitive acquisition agreement.
Jer-Neen is a privately held company located in Lino Lakes, Minn. It is
a value-added manufacturer of precision micro-coils, precision wire forms and
spring components for the medical device industry.
Bio-Vascular, based in St. Paul, develops, manufactures and markets
proprietary specialty medical products for use in thoracic, cardiac, neuro,
ophthalmic and vascular surgery.
# # # #
06/02/98
<PAGE>
EXHIBIT 99.2
FROM: FOR:
Swenson NHB Investor Relations Bio-Vascular, Inc.
1300 Fifth Street Towers, 150 S. 5th St. 2575 University Ave.
Minneapolis, Minn. 55402 St. Paul, Minn. 55114
Contact-Curt Swenson 612/371-0000 Connie L. Magnuson, CFO 612/603-3700
FOR IMMEDIATE RELEASE
BIO-VASCULAR COMPLETES ACQUISITION
OF JER-NEEN MANUFACTURING CO., INC.
ST. PAUL, MINN., AUGUST 3, 1998 - Bio-Vascular, Inc., (Nasdaq: BVAS)
announced today that it has completed the acquisition of Jer-Neen Manufacturing
Co., Inc., Lino Lakes, Minn., a value-added manufacturer of proprietary products
such as micro precision coils, wire forms and spring components used in
implantable defibrillation, interventional medicine and other surgical
applications within the medical device industry.
Bio-Vascular issued 585,872 shares of common stock, together with cash
of $1.8 million, in exchange for all of the common stock of Jer-Neen, including
the assumption of Jer-Neen's liabilities as of the closing. Bio-Vascular paid an
additional $950,000 for a 10-year non-compete agreement covering the former
Jer-Neen shareholders.
"The addition of Jer-Neen's medical components business broadens our
participation in the medical device industry and increases the company's
immediate and long-term revenue potential," said Karen Gilles, president and
chief executive officer of Bio-Vascular. "These benefits can be achieved without
diverting resources that are required for the development, manufacturing and
marketing of Bio-Vascular's current and future branded devices. The combination
achieves a strategic balance in market opportunities, consistent with the
corporate development objectives targeted by the company."
Gilles said Jer-Neen is profitable and should have a neutral to
positive impact on Bio-Vascular's 1998 per-share results. For the nine months
ended July 31, 1998, Jer-Neen had net revenues of approximately $4.1 million
from its medical component business, which grew more than 30 percent over the
first three quarters of 1997. James F. Pfau will continue to manage Jer-Neen as
its president under a three-year employment agreement.
Bio-Vascular, based in St. Paul, develops, manufactures and markets
proprietary specialty medical products for use in thoracic, cardiac, neuro,
ophthalmic and vascular surgery.
# # #
Forward-looking statements contained in this press release are made
pursuant to the safe harbor provisions of the Private Securities Litigation
Reform Act of 1995. There are certain important factors that could cause results
to differ materially from those anticipated by the statements made herein.
Reference is made to the company's Annual Report on Form 10-K for the year ended
October 31, 1997, which is incorporated herein by reference, for a fuller
description of certain of such factors.
8/3/98
